Canada @ BIO 2024
BIO International Convention June 3 – 6, 2024 San Diego Convention Center, California
Once again, BIOTECanada led the Canadian delegation and managed the installation of the Canadian Pavilion with partners from across Canada. BIOTECanada along with the provincial Accord members, the Government of Canada and the Quebec provincial government offered fantastic Canadian programming, and the agenda of activities built on the policy initiatives Canada has established to showcase the innovation and research capacity driving new economic success.
Over 4 days, the Canada Pavilion showcased our life sciences ecosystem and the many opportunities for collaboration within the sector, program panelists and dignitaries provided invaluable perspectives on the rapidly evolving industry, we’re grateful for their expertise. The official Canada@BIO photos are ready! View them here:
Highlights from the Canada Pavilion @ BIO 2024
Canada Pavilion Partners
The Canadian delegation at BIO continues to grow in size and diversity. Each year the industry uses the Canada Pavilion as an opportunity to showcase how important it is for industry and government to work in partnership to advance the Canadian biotech sector. With its immense potential for partnership and collaboration, Canada is dedicated to enhancing health outcomes for patients and families. The passion and cooperative spirit of our ecosystem has the power to transform healthcare.
Thank you to our Canada Pavilion Partners
Canada @ BIO Newsletter
2024 BIO: Canada’s schedule
Monday, June 3
BIO Exhibition Hours: 12:00 PM – 6:00 PM
7 am – 9 am: Alberta’s Advantage in AI/ML & Real World Evidence –
Hosted by: BioAlberta
7:45 am – 10:30 am: Advancements in Life Sciences Sector: Cell and Gene Therapy in Canada
Hosted by: Clinical Trials Ontario, Life Sciences Ontario and Ontario Bioscience Innovation Organization
2:00 pm: Welcome! Official Opening of the Canadian Pavilion on the BIO Exhibition Floor
Location: Canada Pavilion Booth #1321
3:30 pm: Ontario, Canada – Taking Life Sciences to the Next Level
Location: Canada Pavilion Booth #1321
4:00 pm: The Atlantic Advantage
Location: Canada Pavilion Booth #1321
5:00 pm – 7:30 pm: Rendez-vous Québec
Hosted by: BioQuebec and the Government of Quebec
6:00 pm – 9:00 pm: Life Sciences British Columbia International Networking Reception
Hosted by: Life Sciences British Columbia
Tuesday, June 4
BIO Exhibition Hours: 10:00 AM – 6:30 PM
7:00 am – 9:00 am: Canadian Executive Networking Breakfast (For BIOTECanada Members)
Hosted by: BIOTECanada. By invitation only.
7:30am – 9:30am: Medicine, When Precision Matters
Hosted by: Government of Quebec
10:00 am – 11:00 am: Canadian Biomanufacturing : Building for the World
Location:Â Canada Pavilion Booth # 1321
Details: This panel will showcase the world leading expertise leading the growth of the Canadian biomanufacturing sector with the recent milestones of industry leadership and investment success, and highlight how federal government policy is helping to enable Canadian competitiveness in growing, attracting and building the next wave of industry innovation for the global marketplace.
The activity will conclude with and leave time for networking and impromptu 1:1 meetings among the featured Canadian companies, the international guests and prospective clients in attendance at the showcase, as well as some earlier-stage Canadian companies looking to build relationships with prospective future partners or customers.
11:30 am: Announcements from Alberta
Location: Canada Pavilion #1321
Details: Announcements from the Government of Alberta, hosted by BioAlberta.
News Release: Alberta Cancer Foundation, Cancer Care Alberta and industry leaders take to the stage at BIO 2024 to announce collaborative health system project.
3:00 pm: British Columbia Showcase
Location: Canada Pavilion #1321
Details: Learn about British Columbia’s world-class life sciences sector. Featuring speakers from government, association, and industry, understand BC’s competitive advantage in the global ecosystem, and why we are the fastest-growing life sciences sector in Canada.
6:00 pm – 8:00 pm: Atlantic Canada International Networking Reception
Hosted by: Atlantic Canada BioIndustries
8:00 pm – 10:00 pm: Alberta@BIO Reception
Hosted by: BioAlberta
Wednesday, June 5
8:00 am – 9:15am: Efficient Drug Development From Discovery to Market: Leveraging Best in Class Biotech Services
Hosted by: Government of Quebec
10:00 am – 11:30 am: Coast-to-Coast Competition: A company pitch event
Details: Powered by BIOTECanada’s platinum sponsor Mintz, the Coast-to-Coast Competition features companies from across Canada who will deliver a brief pitch, without slides, to the audience and panel of judges. The winner will receive an invitation to attend BIOTECanada’s Investment Summit in March 2025.
Location: Canada Pavilion Booth #1321
1:00 pm – 2:00 pm: Let’s Talk People featuring CASTL, BioTalent Canada, API, and Stemcell Network
Location: Canada Pavilion Booth #1321
Details: This panel will explore the vast job training opportunities for bioscience and biomanufacturing expertise within the Canadian biotech ecosystem. The panel will also showcase a wide range of opportunities found throughout the biotech ecosystem and highlight how organizations are meeting the challenge.
2:00 pm – 5:00 pm: Canada Café: meet the Canadian Trade Commissioner Service
Location: Canada Pavilion Booth # 1321
Details: The Government of Canada’s Trade Commissioner Service (TCS) helps Canadian exporters sell their products and services abroad and grow and succeed through international trade. Businesses that work with the TCS get access to free services, funding and support programs, international opportunities, and network of Trade Commissioners in more than 160 cities worldwide. The TCS will host an Export Café at BIO 2024 on Wednesday, June 5th from 2:00 pm – 5:00 pm, where Trade Commissioners will be present to inform Canadian companies on business opportunities in the USA and abroad. To schedule a meeting contact Natalie Zakhem at natalie.zakhem@international.gc.ca. Trade Commissioners will also be at the Canada Pavilion throughout the conference.
Thursday, June 6
BIO Exhibition Hours: 10:00 AM – 4:30 PM
The Annual Coast-to-Coast Competition @ BIO 2024
Powered by BIOTECanada’s platinum sponsor, Mintz, the Coast-to-Coast Competition featured an esteemed panel of judges:
Powered by BIOTECanada’s platinum sponsor Mintz, the Coast-to-Coast Competition featuring an esteemed panel of judges: Lee Johnson, Mintz; Sarah Williams, adMare BioInnovations; Parimal Nathwani, TIAP – Toronto Innovation Acceleration Partners; Florence Rozen, Fonds de solidarité FTQ; and Lu Han, Lumira Ventures heard short company pitches, without slides, from the following companies:
- Optigo Biotherapeutics (BC)
- HDAX Therapeutics (ON) – WINNER
- Neurenati Therapeutics (QC)
- 3DBioFibR Inc. (NS)
- SeraGene Therapeutics (BC)
Benefits of participating in the Coast to Coast Competition:
- Showcase Opportunity: Pitch your company’s biotech innovations on the Canada stage in the Canada pavilion.
- Exclusive Access: Connect with top-tier investors and influential pharma representatives.
- Advance: The winning company earned a spot to attend the annual BIOTECanada Investment Summit in Whistler, BC, in March 2025—a prime setting for early-stage companies seeking investment opportunities and industry exposure.
2024 Coast to Coast Photo Gallery
BIO Webinars
BIO 2024 Convention Preview & Partnering: BIO’s webinar explores the latest updates and how the BIO One-on-One Partnering™ system can help achieve your business objectives. Review the event program, networking possibilities, basics of the partnering system, and learn the best practices for effective partnering, among other topics!
BIO 2024 Advanced Partnering & Know Before You Go: This webinar is designed to help BIO attendees and exhibitors prepare for their BIO experience. The webinar offers essential on-site information, programming, interactive opportunities, and provides detailed guidance on maximizing the advanced features of the BIO One-on-One Partneringâ„¢ and Exhibitor platforms.
Add your company to the 2024 Canadian Delegation Directory
Canadian Delegation Directory BIO 2024
As per data available as of June 5, 2024. Subject to updating prior to June 25, 2024.
| Company | Member | Location | Primary Segment | Website | Number of Employees | Description | |
|---|---|---|---|---|---|---|---|
| 20/20 OptimEyes Technologies | Hamilton, ON | 2020optimeyes.ca | frances@2020optimeyes.ca | Less than 10 | 20/20 OptimEyes Technologies offers a mucoadhesive drug delivery platform enhancing API solubility and extended release. Validated for eye drops in a pre-clinical glaucoma program, we seek investments and partnerships for mucosal-targeted therapies. | ||
| 35Pharma | BIOTECanada Member | Montreal, QC | Drug, Therapeutic | 35pharma.com | 10 to 50 | 35Pharma is a biopharmaceutical company that rationally designs and develops innovative biologics with best-in-class potential for cardiopulmonary diseases and obesity / T2D. | |
| 3D BioFibR Inc. | Halifax, NS | 3dbiofibr.com | ksullivan@3dbiofibr.com | 10 to 50 | For decades, industry has tried to reassemble collagen back into fibers that match collagen fibers in the body. 3D BioFibR's patented dry spinning has solved this challenge with control over length, orientation and scale of collagen fiber production. | ||
| 5 Prime Sciences Inc. | Montreal, QC | 5prime.com | 10 to 50 | 5Prime Sciences uses genomics and other -omics to accelerate drug development by selecting targets that cause human disease and identifying the right patients for clinical trials | |||
| 9Bio | Quebec, QC | 9bio.ca | decarvalho@9bio.ca | Stands at the confluence of biology, structural engineering, and artificial intelligence, pioneering breakthroughs that will shape tomorrow's healthcare. | |||
| AbCellera | BIOTECanada Member | Vancouver, BC | Drug, Therapeutic | abcellera.com | 200 to 1,000 | AbCellera (Nasdaq: ABCL) discovers and develops antibody medicines for indications across therapeutic areas including cancer, metabolic and endocrine conditions, and autoimmune disorders. AbCellera’s engine integrates technology, data science, infrastructure, and interdisciplinary teams to solve the most challenging antibody discovery problems. AbCellera is focused on advancing an internal pipeline of first-in-class and best-in-class programs and collaborating on innovative drug development programs with partners. | |
| Acuitas Therapeutics, Inc. | Vancouver, BC | Drug, TherapeuticDrug, Therapeutic | acuitastx.com | bd@acuitastx.com | Vancouver-based Acuitas Therapeutics, Inc. is a globally recognized private biotechnology company specializing in the development of delivery systems for nucleic acid therapeutics based on lipid nanoparticles. | ||
| adMare BioInnovations | Vancouver, Toronto, Montreal, BC, ON, QC | Drug, Therapeutic | admarebio.com | flemaitreauger@admarebio.com | With a strong track record of globally-competitive scientific discovery, Canadian life sciences are primed to lead the world. To make this a reality, adMare BioInnovations uses its scientific and commercial expertise, specialized R&D infrastructure, and seed capital to build strong life sciences companies, develop robust ecosystems, and foster industry-ready talent. It re-invests its returns into the Canadian industry to ensure its long-term sustainability. adMare currently has 29 portfolio companies that have attracted $2.3 billion of risk capital, have a combined value of more than $4 billion, and have created over 1,000 jobs in Canada. | ||
| Aird & McBurney LP | Toronto, ON | Services: Legal, Consulting, Business | airdmcburney.com | ksinden@airdmcburney.com | Providing intellectual property services to the life sciences community, including IP strategy, patent preparation and prosecution, patent portfolio management, IP due diligence and freedom to operate analyses. | ||
| Alberta Cancer Foundation | Edmonton & Calgary, AB | albertacancer.ca | christy.holtby@albertacancer.ca | One in two Albertans will be diagnosed with cancer. These are our loved ones, our friends, our neighbours. In partnership with the brightest minds, and with compassionate care, the Alberta Cancer Foundation is making life better for Albertans facing cancer. We are the official fundraising partner for every Alberta Health Services cancer centre in Alberta. ; Our very purpose comes from our desire to create more moments for all Albertans facing cancer, no matter where they live or the type of cancer they are facing. We do this by supporting world-class research and patient care, close to home.; | |||
| Alberta Innovates | Edmonton, AB | albertainnovates.ca | Tim.Murphy@albertainnovates.ca, Ryan.Mercer@albertainnovates.ca | Alberta Innovates provides funding, business advice and connections, applied research and industrial testing facilities to accelerate research and innovations that benefit Albertans. | |||
| Alberta Real World Evidence Unit | Edmonton and Calgary, AB | albertarwe.ca | albertarwe@ualberta.ca | The Alberta Real World Evidence Consortium is comprised of an expert pan-provincial research team from the Universities of Alberta and Calgary, and the Institute of Health Economics. We conduct timely health-focused real world evidence research projects that engage funding partners, decision makers, and knowledge users, as well as uphold academic standards that ensure integrity of results. | |||
| Allumiqs Corporation | Halifax, NS | allumiqs.com | kmaclean@allumiqs.con | 10 to 50 | Allumiqs is a Contract Research Organization (CRO) delivering solutions that help biotech and biopharma companies accelerate their innovations from discovery to patient value. | ||
| Alpha Cognition, Inc | Vancouver, BC | Drug, Therapeutic | alphacognition.com | Info@alphacognition.com | Alpha Cognition is a clinical stage, biopharmaceutical company dedicated to developing treatments for under-served neurodegenerative diseases such as Alzheimer's Dementia and Amyotrophic Lateral Sclerosis (ALS). | ||
| Altis | Toronto, ON | altislabs.com | duoaud@altislabs.com | ||||
| Altus Formulation | BIOTECanada Member | Laval, QC | altusformulation.com | damonsmith@altusformulation.com | Altus Drug Development is a drug development firm specialized in Value-Added Medicines. | ||
| Altus Formulation Inc. | Laval, QC | altusdrugdevelopment.com | damonsmith@altusformulation.com | 10 to 50 | Altus is a specialty pharmaceutical company that designs, develops and delivers patented value-added new medicines in the CNS segment backed by robust patents. | ||
| AmacaThera | BIOTECanada Member | Toronto, ON | Drug, Therapeutic | amacathera.ca | mikejcooke@amacathera.ca | 10 to 50 | AmacaThera, a clinical-stage company developing therapeutics based on our unique long-acting injectable platform (AmacaGel) for localized sustained delivery of small molecules and/or biologics to improve patient outcomes. |
| Amii | Edmonton, AB | amii.ca | jay.summach@amii.ca | 50 to 200 | Amii is an AI Institute in Canada, with decades of expertise leveraging AI with global business partners. We are world leaders in key AI fields including reinforcement learning, explainability, large language models (LLMs), ethics, and health & bio. | ||
| AmorChem Ventures | BIOTECanada Member | Montreal, QC | Investor | amorchem.com | kevin@amorchem.com | Less than 10 | AmorChem II (www.amorchem.com) is a leading VC fund focused on investing in promising life science projects from research-stage to preclinical proof-of-concept, after which we seed newcos and develop technologies to facilitate a Series A financing round |
| Amp Health | St. John's, Newfoundland and Labrador | Digital Health | amphealth.ca | mandy@amphealth.ca | At Amp Health we’re on a mission to help millions of people prevent type 2 diabetes, as the catalyst to keeping blood sugar in range via behaviour change. We pair our novel behavior change models with user data to create interventions when glucose spikes are detected, pairing alerts with actionable steps that a user can take to drastically reduce the impact of blood glucose on their body and reduce pre-diabetes. We're launching pilots in Fall 2024 and raising a pre-seed round - and we’d love to tell you more about how we’re going to reach this massive and growing market to change the future of disease prevention. | ||
| Amplitude Ventures | BIOTECanada Member | Montreal, QC | amplitudevc.com | Our current investment focus is on precision medicine where world-class innovators are driving the future of healthcare | |||
| Ananda Devices - Business Forum | Montreal, QC | anandadevices.com | doreen@anandadevices.com | Less than 10 | Ananda Devices is a Canadian neuroscience technology company that specialize in developing and commercializing nervous systems and other innervated tissue on-a-chip platforms to accelerate drug discovery processes | ||
| Antibe Therapeutics Inc | BIOTECanada Member | Toronto, ON | Drug, Therapeutic | antibethera.com | info@antibethera.com | 10 to 50 | Antibe is a clinical-stage biotechnology company leveraging its proprietary hydrogen sulfide platform to develop next-generation safer therapies to target inflammation arising from a wide range of medical conditions. |
| Apobiologix | Toronto, ON | Drug, Therapeutic | www1.apotex.com | bd2@apotex.com | 1,000 to 10,000 | Apobiologix is a division of Apotex Inc., Canada's leading manufacturer of generic & biosimilar medicines. Our focus is the commercialization of biosimilars & differentiated small molecules delivering quality and value for patients and healthcare systems. | |
| Apotex Corporation | Toronto, ON | Drug, Therapeutic | apotex.com | 1,000 to 10,000 | Apotex Inc. is a Canadian-based global health company that produces high-quality, affordable and complex medicines for patients around the world, with a strategic focus on becoming a Canadian Health Champion and an Americas Partner of Choice. | ||
| Applied Pharmaceutical Innovation (API) | Edmonton, Alberta | Non-Profit, Industry Association, Incubator | appliedpharma.ca | Truong.Ta@appliedpharma.ca | API, one of Canada's largest not-for-profit life sciences organizations, bridges the gap between academic research, development, and commercialization. Enabling innovation among life sciences academia, startups, and small to medium-sized enterprises, API provides direct access to industry capacity and expertise, accelerating testing and development timelines. With a comprehensive suite of services, API serves as a CDMO, CRO, scientific and commercialization one-stop solution for pharmaceuticals, natural health products, medical devices, and diagnostics companies. Further, API is building new capacity to bolster critical medicine supply chains, emphasizing readiness for global health emergencies through initiatives like commercial-scale manufacturing and novel compound discovery platforms. | ||
| ARC Medical Inc. | Richmond, BC | Diagnostics, Device | arcmedinc.com | cspringate@arcmedinc.com | Less than 10 | ARC has the only liquid medical devices that flow, form a temporary barrier film, and prevent surgical adhesions throughout the entire surgical area.Surgeries include gynecological (women's health), abdominal, and orthopedic (knee, shoulder, hip FAI), | |
| Aruna Revolution Health Inc | Dartmouth, NS | arunarevolution.com | rashmi.prakash@arunarevolution.com | Less than 10 | Revolutionary sustainable fibers extracted from agricultural residuals used to make products that are better for our body and the planet, starting with compostable menstrual pads. | ||
| Aspect Biosystems | Vancouver, BC | Drug, TherapeuticDrug, Therapeutic | aspectbiosystems.com | Aspect is pioneering the development of bioprinted tissue therapeutics to transform the treatment of currently incurable diseases. These next-generation cell therapies are designed to replace, repair, or supplement biological function inside the body. The company’s current therapeutic pipeline is focused on metabolic and endocrine diseases such as diabetes, obesity, and congenital liver disorders. | |||
| AstraZeneca | Montreal, QC | astrazeneca.com | patrick.bergeron@astrazeneca.com | AstraZeneca is a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide. | |||
| Avantor | MISSISSAUGA, Ontario | Drug, Therapeutic | avantorsciences.com | jeff.vallerga@avantorsciences.com | More than 10,000 | ||
| AVIR Pharma Inc. | BIOTECanada Member | Blainville, QC | Drug, Therapeutic | avirpharma.com | contact@avirpharma.com | 50 to 200 | AVIR Pharma is a commercial stage speciality pharmaceutical company focused on the commercialization of innovative brand medicines for the Canadian marketplace. |
| Axelys | Quebec, QC | axelys.ca | jesse.vh@axelys.ca | 50 to 200 | Axelys offers consulting and support services in development, intellectual property management, and innovation transfer to all of Quebec's public research establishments. | ||
| Badalone Consulting | Saint Lazare, | videotron.ca | vbadalone@videotron.ca | We have a unique business model that combines an investment arm, scientific support in the non-clinical and clinical spaces, and a semi-virtual outsourcing platform for minimal overhead costs and enables project investment to occur “incrementally” as need | |||
| Banook | Montreal, QC | banookgroup.com | rola.hamed@banookgroup.com | Banook Group is a global provider of cardiac, imaging, and endpoint adjudication central services to the pharmaceutical, biotechnology, and medical device industries. | |||
| Bausch Health | Laval, QC | bauschhealth.com | martin.barbeau@bauschheath.com | Bausch Health Companies Inc. develop, manufacture and market a range of products primarily in gastroenterology, neurology, dermatology and international pharmaceuticals. | |||
| Bayshore Specialty Rx | Mississauga, ON | Services: Contract Research, Development, Manufacturing | bayshore.ca | bgood@bayshore.ca | health care service provider: 3PL, wholesale, home nursing, specialty pharmacy, patient support services | ||
| BCF llp | Montreal, QC | Services: Legal, Consulting, Business | bcf.ca | Emma.saffman@Bcf.ca | Legal services | ||
| Beigene | Toronto, ON | Drug, Therapeutic | beigene.ca | grant.perry@beigene.com | BeiGene Canada's purpose is to ensure that Canadian patients, caregivers, clinicians, and investigators have timely access to novel, effective and affordable oncology medications. We are advancing an innovative, high-value product portfolio for patients globally, providing best in-class medications for blood cancers and solid tumors. | ||
| Bereskin & Parr LLP | Toronto, Ontario | Services: Legal, Consulting, Business | bereskinparr.com | As one of the largest and top-rated intellectual property law firms in Canada, Bereskin & Parr specializes in intellectual property law across twenty-six industry practice areas. We are your partners in brilliance, here to provide solutions that safeguard the value of ideas to help businesses today, and tomorrow. Bereskin & Parr’s Life Sciences practice group is comprised of professionals with diverse technical backgrounds and industry expertise, ensuring members stay at the forefront of trends in the ever-changing industry, and in the law that relates to it. | |||
| BioAlberta - Exhibitor | BIOTECanada Member | Edmonton, AB | Non-Profit, Industry Association, Incubator | bioalberta.com | admin@bioalberta.com | Less than 10 | BioAlberta is a member-driven, not for profit industry association that represents and advocates for Alberta's vibrant and diverse life sciences industry. |
| BioAro Inc | Calgary, AB | BioAro.com | anmolmd@bioaro.com | BioAro is a Biotechnology company specializing in Precision Health, Genomics, and Longevity Medicine. It offers Multi-Omic Lab services, State of the Art AI-Powered Real Time Genomic Software solutions such as PanOmiQ - World's Fastest Multi-Omic Software, BioEMR, BioSport, and BioGut. Its RnD division offers support for various clinical trials, product development and clinical validation services across North America. It also has Precision Health Clinics in Canada and Dubai, UAE. | |||
| BioCanRx | BIOTECanada Member | Ottawa, ON | Non-Profit, Industry Association, Incubator | biocanrx.com | smichaud@biocanrx.co | Less than 10 | The BioCanRx vision is to turn all cancers into curable diseases. We invest in leading edge immune oncology research translating world-class technologies from the lab into early phase clinical trials. BioCanRx provides researchers with access to funding, |
| Biodextris | BIOTECanada Member | Laval, QC | biodextris.com | info@biodextris.com | 10 to 50 | Biodextris is a Contract Development and Manufacturing Organization focused on the early stage development of vaccines and biologics. | |
| Biohubx | Calgary, AB | biohubx.com | elisa@biohubx.com | Biohubx is a not-for-profit that supports life sciences and health-tech companies that are at the scale-up stage. We provide mentorship, programming, and access to technical infrastructure, including laboratory space prepped for regulatory certification and manufacturing. We will be launching a second facility in Calgary, centred in the northwest health tech cluster that includes the Calgary Cancer Centre (the largest oncology center in Canada), the University of Calgary, Foothills Hospital, Alberta Children's Hospital, and the Southern Alberta Institute of Technology. We offer international companies who are planning to expand in the North American market tailored support and a de-risked beachhead opportunity situated in a strategic and central location. ; ; At BIO, we are looking to connect with industry partners and SMEs who would benefit from being plugged into an ecosystem designed for commercialization. The Province of Alberta has competitive conditions for business with the lowest corporate income tax rate in Canada and no sales tax. To round it out, the sunny City of Calgary was named the third most livable city in the world in 2022. | |||
| Biologics Manufacturing Center | BIOTECanada Member | Montreal, QC | bmc-cppb.ca | leila.sabouri@bmc-cppb.ca | 50 to 200 | The Biologics Manufacturing Centre (BMC) Inc. is an end-to-end GMP biomanufacturing facility, supporting the growth of domestic biomanufacturing production capacity, ensuring that vaccines and other biologics can be safely manufactured in Canada. | |
| BioQuebec | BIOTECanada Member | Laval, QC | bioquebec.com | blarose@bioquebec.com | Quebec's largest biotechnology and life sciences network. | ||
| BioScript Logistics | Oakville, Ontario | Drug, Therapeutic | bioscript.ca | starantino@bioscript.ca | From Importation to Patient, BioScript supports a broad range of complex drug therapies and delivers full-service solutions for specialty care — from our patient support programs, wholesale pharmaceutical distribution and third-party logistics to our clinics and pharmacies that serve thousands of Canadians coast to coast every year. | ||
| BioSyent | Mississauga, ON | Drug, Therapeutic | biosyent.com | info@biosyent.com | 50 to 200 | BioSyent Inc is a profitable, growth-oriented, publicly listed Canadian Specialty Pharmaceutical company based in Toronto that sources, acquires/in-licenses and markets pharmaceutical products in Canada and in International markets. | |
| BioTalent Canada | BIOTECanada Member | Ottawa, ON | Non-Profit, Industry Association, Incubator | biotalent.ca | operations@biotalent.ca | 10 to 50 | BioTalent Canada is a labor market research organization that bridges the gap between academia and the biotech industry through its products and services. |
| BIOTECanada | Ottawa, ON | Non-Profit, Industry Association, Incubator | biotecanada.ca/en | info@biotech.ca | Less than 10 | BIOTECanada is the national industry association with over 200 members located nation wide, reflecting the diverse nature of Canada's health, industrial and agricultural biotechnology sectors. | |
| Biotech City | Laval, QC | citebiotech.com | j-m.juteau@laval.ca | The Biotech City is a biotechnology and life sciences hub of the Metropolitan Montreal including world-renowned biopharmaceutical firms and research institutes employing more than 5,000 individuals. | |||
| Biotech City - Laval | Laval, QC | Non-Profit, Industry Association, Incubator | citebiotech.com | jmjuteau@citebiotech.com | The Biotech City is a life science hub in the Metropolitan Montreal including 120 companies, a research institute, a startup incubator employing more than 5,500 highly skilled people. | ||
| BioTraceIT | , | paintrace.com | info@biotraceit.com | 10 to 50 | Prescriptive medicine through individual outcomes. PainTrace® is individual objective, actionable real-time, acute and chronic pain responses. Quantify pain during examination, surgery, or over time in response to treatment. POC or remote. | ||
| BioVectra | BIOTECanada Member | Charlottetown, PE | biovectra.com | info@biovectra.com | 200 to 1,000 | BioVectra is a global CDMO serving pharmaceutical, biotech, and gene therapy companies with full-service cGMP outsourcing solutions for intermediates, APIs, Drugs Substances and Drug Products. We operate out of 5 cGMP facilities located in North America. | |
| Blake, Cassels & Graydon LLP | BIOTECanada Member | Calgary, Montreal, Ottawa, Toronto, Vancouver, | Services: Legal, Consulting, Business | blakes.com | joseph.garcia@blakes.com | Blakes is a leading Canadian law firm with a long history of representing pioneers and leaders in the life sciences industry. We advise Canadian and foreign companies operating in Canada on domestic and cross border business activities. Clients look to us for the full range of legal services to address their complex business needs including commercialization, regulatory, private finance, capital markets and M&A. | |
| Borden Ladner Gervais LLP | Ottawa; Toronto; Montreal; Vancouver, ON; QC; BC | Services: Legal, Consulting, Business | blg.com | kpejemsky@blg.com | Borden Ladner Gervais LLP (BLG): As the largest, truly full-service Canadian law firm, BLG delivers practical legal advice for domestic and international clients across more practices and industries than any Canadian firm. With 800 lawyers, intellectual property agents and other professionals, BLG serves the legal needs of businesses and institutions across Canada and beyond – from M&A and capital markets, to disputes, financing, and trademark & patent registration. Innovation in life sciences creates an ever-changing landscape. Whether you are an early stage startup or established company, you need a well-versed legal team that can represent you on all the legal and strategic matters relevant to your business. Our team of more than 50 life science lawyers and patent agents, includes many individuals who hold PhDs or Master’s degrees in the life sciences, who bring an in-depth understanding of the science and technology on which your business is built to their legal advice. A number of our professionals also have held relevant industry related positions, which provides us with working knowledge and a genuine comprehension of this sector – both where it has been and where it is heading. Clients can expect to find a team of professionals at BLG that is entrepreneurial and business minded. We have extensive experience assisting clients in structuring and documenting both standard and unique business structures, including mergers, divestitures, acquisitions, joint ventures, licenses, and partnerships. We also work with clients from universities, to start-ups, to SMEs to multinationals to ensure that their innovations are protected in the best possible manner under Canada’s Patent Act and the accompanying regulatory structure that affects companies looking to bring a patented medicine to market. We have specialized litigators who are experienced in running both complex patent infringement and product liability trials once those products enter the market. Our Privacy, Competition, Advertising, Government Relations, Labour and Employment and Tax Groups also regularly serve BLG’s Life Sciences clients. With such a cross-disciplinary practice, you can look to BLG to act as your trusted and well-connected advisor. | ||
| BrevisRefero Corporation | Milton, ON | Drug, Therapeutic | brevisrefero.com | t.c@brevisrefero.com | 10 to 50 | Driving life-saving products to the clinic for patients that need them the most, BrevisRefero are biologics drug development CMC professionals with deep expertise in program outsourcing and delivery. | |
| C3i | Montreal, QC | centrec3i.com | sdonaldson@centrec3i.com | C3i supplies advanced cell and gene products that meet regulatory requirements worldwide. | |||
| C3i Center | Montreal, QC | centreC3i.com | sdonaldson@centrec3i.com | Cell & Gene Therapy CDMO/Partner/Investor | |||
| Caledon Bioscience Inc. | Laval, QC | Drug, Therapeutic | caledonbio.com | info@caledonbio.com | 10 to 50 | * We are not accepeting requests from service providers.* Caledon Bioscience is a privately held development stage biopharmaceutical company focused on developing small molecule therapeutics that modulate G protein-coupled receptors or GPCR pathways. | |
| Calgary Economic Development | Calgary, AB | calgaryeconomicdevelopment.com/sectors/life-sciences | ltang@calgaryeconomicdevelopment.com | Calgary Economic Development works with companies and organizations that are interested in developing their technologies or growing and expanding their business in Calgary, Alberta. We connect people and companies with resources that can help them grow their careers and businesses, thrive in new locations or markets, and feel at home in our community. Calgary is home to more than 120 life sciences companies, from emerging startups to established medtech/healthtech/biotech firms. With leading research innovation in cardiovascular diseases, oncology, neuroscience, microbiome, animal health, and sports medicine, the city is an active hub for life sciences innovation. | |||
| Calian | Ottawa, Ontario | Services: Contract Research, Development, Manufacturing | calian.com | patricia.moore@calian.com | Calian CRO offers full-service clinical trial solutions for Phase I-IV projects, as well as flexible Functional Service Provider staffing solutions. Calian PSP designs and implements customized PSPs that connect patients, healthcare professionals and pharmacies to deliver a high-quality patient and physician experience. Calian Digital Health solutions are designed to enhance access to high-quality healthcare by seamlessly connecting patients and care providers. Our solutions facilitate interoperability, secure communication and collaboration within care teams to improve patient outcomes. | ||
| Canadian Alliance for Skills and Training (CASTL) | BIOTECanada Member | Charlottetown, PE | castlcanada.ca | info@castlcanada.ca | 10 to 50 | The Canadian Alliance for Skills and Training in Life Sciences (CASTL) provides world-class technical skills development in life sciences specializing in biopharmaceutical manufacturing. | |
| CanAm Bioresearch Inc. | Winnipeg, Manitoba | Services: Contract Research, Development, Manufacturing | canambioresearch.com | adfriesen@medicure.com | CanAm Bioresearch is a well-established pharmaceutical CRO specializing in medicinal chemistry. We provide medicinal chemistry, custom organic synthesis, analytical chemistry services and bioanalytical testing in many diverse therapeutic areas. | ||
| Capital BioVentures | Ottawa, Ontario | Non-Profit, Industry Association, Incubator | capitalbioventures.ca | julia@capitalbioventures.ca | Capital BioVentures is an Ottawa Canada founded wet-lab accelerator program that removes hurdles for our Canadian innovators, while fostering a collaborative and cohesive ecosystem.Capital BioVentures was founded by a group of passionate entrepreneurs, biotech professionals and institutional experts local to the Ottawa ecosystem: Julia Pomoransky, Jeff Smirle, Maura Campbell, and David Stojdl. We have a singular focus: build more successful biotech companies that commercialize and scale in Canada. With this mission, we are offering seed-staged therapeutics and diagnostic companies:1. Early-stage funding in the form of cash2. Access to dedicated drug and corporate development biotech professionals3. Access to high quality, equipment fit up lab spacePlease reach out to learn more ! | ||
| Cardiol Therapeutics Inc. | Oakville, ON | Drug, Therapeutic | cardiolrx.com | john.geddes@cardiolrx.com | 10 to 50 | Cardiol is a clinical-stage Phase 2 life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. Our purpose is to heal the heart with innovative science. | |
| Catalis | Montreal, QC | catalisquebec.com | dlaberge@catalisquebec.com | CATALIS has an extended government mandate aimed at increasing the number of clinical trials carried out by companies in Quebec and facilitating collaboration between the various players in the life sciences. | |||
| Centre for Addiction & Mental Health | Toronto, ON | camh.ca/en/science-and-research | klara.vichnevetski@camh.ca | 1,000 to 10,000 | The Centre for Addiction and Mental Health (CAMH) is Canada's largest mental health and addiction teaching hospital, as well as one of the world's leading research centres in the area of addiction and mental health. | ||
| Centre for Commercialization of Regenerative Medicine (CCRM) | BIOTECanada Member | Toronto, ON | Drug, Therapeutic | ccrm.ca | cdmo@ccrm.ca | 50 to 200 | Centre for Commercialization of Regenerative Medicine in Toronto. |
| CGI | Montreal, QC | cgi.com | marcel.bassil@cgi.com | More than 10,000 | CGI works with pharma, biotech and medical device companies from early stage development, to data capture, regulatory submission & late stage development. We partner with them to minimize regulatory and competitive impacts and maximize revenue potential. | ||
| City of Brampton | Brampton, ON | Non-Profit, Industry Association, Incubator | investBrampton.ca | martin.bohl@brampton.ca | Less than 10 | Provide access to government services, connections to hospitals, and local incubators for health and related services including cybersecurity. | |
| City of Mississauga | Mississauga ( Greater Toronto Area), ON | Non-Profit, Industry Association, Incubator | thefutureisunlimited.ca | cheryl.peters@mississauga.ca | Are you a Life Sciences company who are in late stage development (late phase 2 and phase 3 drug) or a medical device, technology or service looking to enter and commercialize in Canadian market?We are your partners to help through this process | ||
| Clinical Trials Alberta | Edmonton, AB | clinicaltrialsab.ca | info@clinicaltrialsab.ca | Clinical Trials Alberta (CTA) is a collaboration of government, academic institutions, and healthcare delivery organizations who contribute to building Alberta's clinical trial environment. CTA aims to:; • Promote Alberta's unique assets for conducting high-quality clinical trials.; • Attract industry research and development investment to the province.; • Offer centralized access for industry to engage with Alberta's clinical trial assets.; • Enable effective collaboration between industry sponsors and Alberta investigators, sites, and services providers.; | |||
| Clinical Trials Ontario | Toronto, Ontario | Non-Profit, Industry Association, Incubator | ctontario.ca | elena.trebinjac@ctontario.ca | Established in 2012 with support from the Government of Ontario, Clinical Trials Ontario (CTO) is a leading non-profit organization in the clinical trials community dedicated to strengthening, promoting and capitalizing on Ontario’s competitive advantages for conducting high-quality clinical trials. We foster partnerships and work collaboratively with the clinical trials community to improve the clinical trials environment, cut through red tape and attract investment to the province, while supporting the highest ethical and quality standards. | ||
| Compliance Team | Buffalo, New York | Services: Legal, Consulting, Business | complianceteamllc.com | dgionis@complianceteamllc.com | Compliance Team LLC provides FDA consulting support to help pharma operate in a compliant regulatory environment while also providing resources to help complete quality and CQV projects. We are just over the Peace Bridge. | ||
| Congruence Therapeutics | Montreal, | Drug, Therapeutic | congruencetx.com | 10 to 50 | Congruence Therapeutics is building a pre-eminent next-generation drug discovery company by harnessing a distinctive, scalable computational platform, Revenir™, to rapidly and efficiently discover a pipeline of small molecules to correct severe disease | ||
| Consulate General of Canada - Trade Commissioner Services | Boston, All | Government | tradecommissioner.gc.ca | philip.bunsick@international.gc.ca | The Trade Commissioner Service will have representatives from the USA and around the world. We look forward to working with the attending Canadian companies to help you grow, partner and collaborate with International partners. Come meet with us and learn how the TCS can help your company or organization. | ||
| Copoly.ai | Toronto, Ontario | Services: Contract Research, Development, Manufacturing | copoly.ai | Our mission is to empower the pharmaceutical and healthcare sectors by equipping them with advanced Al-driven data analysis tools. We are dedicated to being a part of a healthier future, where precision medicine and accelerated drug discovery lead to better patient outcomes. | |||
| Corealis Pharma | Laval, QC | corealispharma.com | yves.roy@corealispharma.com | Corealis specializes in pharmaceutical oral solid dosage form development and Phase I/II clinical supply manufacturing. | |||
| Corealis Pharma, Inc | Laval, QC | corealispharma.com/en | info@corealispharma.com | 10 to 50 | COREALIS Pharma is a private company offering formulation development and clinical supplies manufacturing services to pharmaceutical and biotech companies. | ||
| Covar Pharmaceuticals Inc. | BIOTECanada Member | Mississauga, ON | covarpharma.com | inquiries@covarpharma.com | 10 to 50 | Covar Pharmaceuticals delivers customized services for pharmaceutical development of new or existing drugs, novel delivery systems, and complex formulations. | |
| CPDC | , ON | cpdc.ca | catherine@cpdc.ca | The Centre for Probe Development and Commercialization (CPDC) specializes in nuclear medicine. We are seeking radiopharma in-licensing and direct investment opportunities in therapeutics, diagnostics and related technologies. | |||
| CQDM | BIOTECanada Member | Montreal, QC | cqdm.org | info@cqdm.org | 10 to 50 | CQDM is a Canadian, not-for-profit, research consortium driven by the mission to fund the development of innovsative biopharmaceutical R&D to accelerate the development of safer and more effective drugs, vaccines and diagnostics. | |
| CQIB - Quebec Life Sciences Incubator | , | cqib.org | marketing@cqib.org | 10 to 50 | TURNKEY LABORATORIES TO INCUBE YOUR BUSINESS AND SUPPORT YOUR GROWTH- 30 000 sf (2800m2) of laboratories (BSL2) and offices ??- Access to a range of laboratory equipment including: qPCR, HPLC, freezers, hoods, plate readers, scales, centrifuges, microsc | ||
| CTI Life Sciences Fund | Montreal, Quebec | Investor | ctisciences.com | xhang@ctisciences.com | CTI Life Sciences Fund (CTI) is a leading Canadian life sciences venture capital (VC) firm that invests where the needs of pharma and patients intersect. Our core investment focus is biotherapeutic companies in the pre-clinical to early-clinical stage. | ||
| Custom Biologics | Toronto, ON | custombiologics.com | info@custombiologics.com | 10 to 50 | A large molecule bioanalytical CRO helping companies advance biotherapeutic and gene therapy drug development through pre-clinical CMC characterization, clinical pharmacokinetic and immunogenicity testing. | ||
| Cybin | Toronto, ON | Drug, Therapeutic | cybin.com | irteam@cybin.com | 50 to 200 | Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. | |
| Dalhousie University | Halifax, NS | dal.ca | Dalhousie University combines high-impact research, meaningful teaching, and a deep sense of social responsibility that inspires our diverse community to make a difference here in Nova Scotia, across Canada, and on the global stage. | ||||
| Deep Genomics | Toronto, | deepgenomics.com | 50 to 200 | ||||
| Diex Recherche | Sherbrooke, Québec | Services: Contract Research, Development, Manufacturing | diex.ca | rszypura@diex.ca | Diex Recherche is a network of 5 state-of-the-art clinical sites, all located in the province of Quebec, Canada, with 18 years of proven success. We specialize in conducting clinical trials, with a focus on phases 2 and 3. Our unique business model ensures collaboration with over 55 Investigators and KOLs, each specialized in their therapeutic areas. This allows us to conduct projects in Vaccines, Cardiology, Immunology, Metabolic and Endocrine Diseases, Gastroenterology, Urology, Gynecology, Infectious diseases, Respiratory Diseases, CNS, and many more. | ||
| DRI Healthcare | Toronto, ON | Investor | drihealthcare.com | info@drihealthcare.com | 10 to 50 | DRI Healthcare is a pioneer and global leader in healthcare royalty investing with over two decades of experience. | |
| Duchesnay Inc. | Blainville, QC | Drug, Therapeutic | duchesnaypharmaceuticalgroup.com/en | bd@duchesnay.com | 50 to 200 | Duchesnay Pharmaceutical Group headquartered in Blainville Quebec is a multinational pharmaceutical company that consists of six entities created to promote the well-being and health of individuals at every stage of their lives. | |
| Dynacare | Brampton, ON | Diagnostics, Device | dynacare.ca | beauchamps@dynacare.ca | Dynacare, a LabCorp company, is committed to being Canada’s health and wellness solutions leader. LabCorp (NYSE: LH), an S&P 500 company, is a leading global life sciences company that is deeply integrated in guiding patient care, providing comprehensive clinical laboratory and end-to-end drug development services. Dynacare (formerly Gamma-Dynacare Medical Laboratories) is one of Canada’s largest, most established health solutions companies with a history that spans more than 50 years. Headquartered in Brampton, Ontario, we have operations in Quebec, Ontario, Manitoba, Alberta and British Columbia. Every year, we take care of more than 10 million Canadians from coast to coast to coast through: the accurate and timely delivery of test results and other health-related services to healthcare professionals across the country; a personalized health management portal that helps Canadians take a more active role in their healthcare; and pathology centres of excellence in key therapeutic areas, as well as leading edge services in genetic testing, companion diagnostics and immunohistochemistry. | ||
| Edesa Biotech Inc. | Markham, ON | Drug, Therapeutic | edesabiotech.com | investors@edesabiotech.com | We are a biopharmaceutical company focused on acquiring, developing and commercializing clinical-stage drugs for inflammatory and immune-related diseases with clear unmet medical needs. | ||
| Edmonton Global | Edmonton, AB | edmontonglobal.ca | rsikora@edmontonglobal.ca | Edmonton Global is a foreign direct investment (FDI) and international business development agency, located in the Western Province of Alberta in Canada where we represent the Edmonton Region. The Edmonton region is accelerating research and development and increasing productivity in life sciences and has strengths in pharmaceutical manufacturing, drug discovery, nutraceuticals, diagnostics, medical devices, and sits at the convergence of artificial intelligence and health.; Companies in the region benefit from operating in Alberta which is home to Canada's largest, fully integrated healthcare system that serves a diverse population of 4.3 million people.; ; Collaboration, digitalization, strong academic and industry partnerships paired with an entrepreneurial mindset have led to a boom in this sector. The region is teeming with potential strategic partners for anyone looking to invest.; ; Health and life science companies in the Edmonton region are part of a strong, growing, and tight-knit community working at the cutting edge of scientific breakthroughs. Scientists are at the forefront of research in diabetes, virology, and precision health, and we have world class facilities to prove it.; ; Anchored by world class institutes such as the University of Alberta and the Alberta Machine Intelligence Institute whom are ranked top 3 Globally for their innovation and excellence in Artificial Intelligence. | |||
| Entos Pharmaceuticals | BIOTECanada Member | Edmonton, AB | Drug, Therapeutic | entospharma.com | jailal.ablack@entospharma.com | 50 to 200 | Entos Pharmaceuticals' Fusogenix™ Proteo-Lipid Vehicle™ (PLV™) platform, enables precision non-viral, re-dosable delivery of all nucleic acids payloads (DNA, RNA, or combinations), ushering in the new era of genetic medicine. |
| Epitopea | BIOTECanada Member | Montreal, QC | Drug, Therapeutic | epitopea.com | info@epitopea.com | Less than 10 | Epitopea is a global leader in exploiting a novel class of shared, non-mutated tumour-specific antigens (TSAs) designed to treat broad cancer patient populations. |
| Esphera SynBIO | Ottawa, ON | Drug, Therapeutic | synapseconsortium.com | lichtyb@mcmaster.ca | |||
| Esphera SynBio Inc | , | Drug, Therapeutic | EspheraSynBio.ca | blichty@espherasynbio.ca | Less than 10 | Esphera SynBio is a pre-clinical staged company with a pipeline of assets in both oncology and infectious disease. Esphera is looking for strategic partnerships to accelerate our development. | |
| Eupraxia Pharmaceuticals | Victoria, BC | Drug, TherapeuticDrug, Therapeutic | eupraxiapharma.com/home | Eupraxia is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release products that have the potential to address therapeutic areas with high unmet medical need. The Company strives to provide improved patient benefit and has developed technology designed to deliver targeted, long-lasting activity with fewer side effects. DiffuSphere™, a proprietary, polymer-based micro-sphere technology, is designed to facilitate targeted drug delivery, with extended duration of effect, and offers multiple, highly tuneable pharmacokinetic (PK) profiles. This investigational technology can be engineered for use with multiple active pharmaceutical ingredients and delivery methods. Its lead products are EP-104IAR which has completed Phase 2b for knee OA, and EP-104GI which is in Phase 1b/2a for EoE and GI strictures. | |||
| Eupraxia Pharmaceuticals Inc. | Victoria, BC | Drug, Therapeutic | eupraxiapharma.com | 10 to 50 | Eupraxia develops new applications for existing products using its highly differentiated delivery technology. Its lead products are EP-104IAR which is entering Phase 3 for knee OA, and EP-104GI which is in Phase 1b/2a for EoE and GI strictures. | ||
| Eurofins CDMO Alphora Inc. | Mississauga, ON | Services: Contract Research, Development, Manufacturing | eurofins.com | CDMOAlphora@bpt.eurofinsca.com | 200 to 1,000 | Eurofins CDMO Alphora Inc. is a full service contract research organization, with a specialization in API and Drug Product development and manufacturing services for complex small molecules and biologics, including highly potent compounds and ADCs. | |
| EVERSANA Canada | Toronto, Ontario | Services: Legal, Consulting, Business | eversana.com | zahir.ratanshi@eversana.com | EVERSANA is a global services provider to the life science industry with integrated solutions rooted in the patient experience. EVERSANA's capabilities span all stages of the product lifecycle to deliver long-term, sustainable value for patients, prescribers, channel partners and payers. The company serves hundreds of organizations, from start-ups to big pharma, to advance life science services for a healthier world. | ||
| Eyam Vaccines and Immunotherapeutics | BIOTECanada Member | , BC | eyamhealth.com | contact@eyamhealth.com | 10 to 50 | EYAM is a platform company with strong animal efficacy data for a self-amplifying AI-informed RNA/DNA smart vector. We are seeking investment and strategic partnership opportunities. | |
| Feldan Therapeutics | BIOTECanada Member | Quebec, QC | Drug, Therapeutic | feldan.com | vmenard@feldan.com | 10 to 50 | Feldan Therapeutics is a preclinical biotechnology company developing leading-edge treatments based on a unique intracellular delivery technology; the Feldan Shuttle. |
| Find Therapeutics | BIOTECanada Member | Montreal, QC | Drug, Therapeutic | findtherapeutics.com | info@findtherapeutics.com | Less than 10 | Find Therapeutics, is dedicated to the development of next generation therapies to treat CNS demyelinating and inflammatory autoimmune gastrointestinal diseases. |
| Fonds de recherche du Quebec Sante | Montreal, QC | frq.gouv.qc.ca/sante | paul.larcheveque@capcogito.com | Disease prevention. Better care. Our scientists are looking for solutions so that we can live healthier lives. At the Fonds de recherche du Quebec – Sante (FRQS), we offer them financial support while ensuring the strategic and coherent development of health science research in Quebec. | |||
| Fonds FTQ | BIOTECanada Member | Montreal, QC | fondsftq.com | gguertin@fondsftq.com | The Fonds FTQ offers local savings solutions to Quebecers, investment advice and financing to local businesses. | ||
| FreshLeaf Marketing | Guelph, Ontario | Services: Legal, Consulting, Business | freshleafmarketing.ca | jennifer@freshleafmarketing.ca | At FreshLeaf Marketing, we help multi-6 and 7-figure B2B life science businesses stand out, get found, and gain more leads through a strategic, integrated marketing approach. Learn more at www.freshleafmarketing.ca | ||
| Future Fields | Edmonton, AB | futurefields.io | chris@futurefields.io | 10 to 50 | Difficult protein expression that scales by harnessing the multicellular expression prowess of Drosophila melanogaster. We help biotech/biopharma conserve budget and make great proteins, unlocking new products and workflows. | ||
| Galenvs | Montreal, QC | galenvs.com | contact@galenvs.com | 10 to 50 | Galenvs is a specialized precision developer & manufacturer of nanomaterials and DNA/RNA oligonucleotides for therapeutics and diagnostic applications, offering services from proof-of-concept through in-vitro validation and pilot-scale production. | ||
| Gene Bio Medical | RICHMOND, British Columbia | Diagnostics, Device | genebiomedical.com | jessica.hu@genebiomedical.com | Gene Bio Medical excels in in vitro diagnostics (IVD), focusing on immunoassay, molecular diagnostics, microbiological testing, precision medicine, and infectious disease testing. With advanced R&D and emerging technologies like AI and biosensing, we develop high-performance IVD products, aiming to lead global innovation and enhance clinical diagnostics. | ||
| Genome British Columbia | Vancouver, British Columbia | Non-Profit, Industry Association, Incubator | genomebc.ca | sgill@genomebc.ca | Genome BC is a not-for-profit organization supporting world-class genomics research and innovation to grow globally competitive life sciences sectors and deliver sustainable benefits for British Columbia, Canada and beyond. The organization’s initiatives are improving the lives of British Columbians by advancing health care as well as addressing environmental and natural resource challenges. In addition to scientific programming, Genome BC works to integrate genomics into society by supporting responsible research and innovation and fostering an understanding and appreciation of the life sciences among educators, students and the public. | ||
| Genome Quebec | Montreal, QC | genomequebec.com | jrlandry@genomequebec.com | Genome Quebec's mission is to catalyze the development and excellence of genomics research, its integration, and democratization. | |||
| GENVIRA BIOSCIENCES INC. | BIOTECanada Member | Ottawa, ON | genvira.com | jiahu.wang@genvira.com | 10 to 50 | Viral Vector Design, Engineering, Characterization and Production for clinical evaluation. | |
| GL CHEMTEC INTERNATIONAL LTD. | Oakville, ON | Services: Contract Research, Development, Manufacturing | glchemtec.ca | 10 to 50 | |||
| GlycoNet Financial Administrator | Edmonton, AB | glyconet.ca | sxanthoudakis@glyconet.ca | Less than 10 | GlycoNet is a national research network leveraging glycomics to develop innovative technologies, diagnostics, treatments, and vaccines for multiple diseases. | ||
| GoodCap Pharmaceuticals | BIOTECanada Member | , | Drug, Therapeutic | goodcap.com | dhudson@goodcap.com | GoodCap Pharmaceuticals is targeting psychiatric and neurodegenerative disorders by combatting a broad array of inflammatory cytokines associated with neuroinflammation and oxidative stress. | |
| Groupe Parima | Montreal, QC | groupeparima.com | bd@groupeparima.com | 50 to 200 | Groupe PARIMA is a CDMO, specialized in the development & manufacturing of non-sterile liquids, suspensions and semi-solid drug products. We have been favorably inspected by the EMA, TMMDA, FDA and Health Canada. | ||
| HDAX Therapeutics | , | Drug, Therapeutic | hdaxtx.com | nabanita@hdaxtx.com | Less than 10 | HDAX Therapeutics is a preclinical stage company developing next-gen HDAC6-targeting precision therapeutics for neurological and cardiometabolic diseases. | |
| Hermay Labs Corporation | Edmonton, AB | hermaylabs.com | jyao@hermay.ca | Hermay Labs Corporation is a Canadian CRO that provides medicinal chemistry and custom synthesis (intermediates, building blocks, final compounds, reference compounds, etc) services with high quality, quick delivery, and reasonable prices. ; We also provide computer aided drug design and modeling, docking, and “in silico” predicting ADME, toxicity, and PK. ; We are based in Edmonton, Alberta, Canada, and operate out of a 10,000-square-foot laboratory in Edmonton Research Park. Our facility can synthesize complex compounds ranging from milligrams to kilograms. Since starting in 2019 we have completed multiple projects in analytic chemistry, medicinal chemistry, custom synthesis, and scaling up manufacturing. | |||
| HisTurn | Montreal, QC | histurnfertility.com | sarah.kimmins@histurnfertility.com | Less than 10 | HisTurn is an epigenomics and AI biotechnology company. Our first market offering uses precision medicine for the diagnosis and treatment of male infertility. This approach will be extended for prostate cancer and metabolic disease among others. | ||
| Hologic | Montreal, QC | Diagnostics, Device | hologic.com | isabelle.fortier@hologic.com | Using the approach they call "The Science of Sure", Hologic is the world's number 1 in women's health, aiming to improve and save lives through early detection and treatment. | ||
| HTuO Biosciences | BIOTECanada Member | Vancouver, BC | htuobio.com | info@htuobio.com | 10 to 50 | HTuO Biosciences is a computational biotechnology company. Utilizing a novel molecular physics model we aim to accelerate drug optimization and discovery. | |
| Idorsia Pharmaceuticals Canada Ltd | Pointe-Claire, QC | idorsia.com | ron.morcos@idorsia.com | Idorsia Canada is a subsidiary of Idorsia Pharmaceuticals Ltd. and is responsible for bringing Idorsia's innovative medicines to patients in Canada. | |||
| Immugenia Inc. | BIOTECanada Member | Sherbrooke, QC | Drug, Therapeutic | immugenia.com | Immugenia Inc. is an immuno-oncology company developing a novel approach to CAR therapy by engineering hematopoietic stem cells using specific synthetic promoters leveraging both T and NK cells to treat cancer and prevent relapses, potentially for life | ||
| Immune Biosolutions inc | Sherbrooke, QC | Drug, Therapeutic | immunebiosolutions.com | info@ibiosolutions.com | 10 to 50 | Immune Biosolutions is a company that utilizes the unique properties of the avian immune system to generate novel antibodies for the development of immuno-therapies, notably in cancer. | |
| ImmunoBiochem Corporation | Toronto, ON | Drug, Therapeutic | www immunobiochem.com | ceo@immunobiochem.com | Less than 10 | ImmunoBiochem is a biotech developing novel tumor microenvironment-targeted bioconjugates (ADCs, ISACs) against heterogeneous solid tumors via targets amplified in the cancer cell secretomes, as well as degrader-based bioconjugates (DACs) for immunology. | |
| ImmunoPrecise Antibodies Ltd. | BIOTECanada Member | Victoria, BC | ipatherapeutics.com | solutions@ipatherapeutics.com | 50 to 200 | IPA is a biotherapeutic research and technology company that leverages systems biology, multi-omics modeling and complex artificial intelligence systems to support its proprietary technologies in bioplatform-based antibody discovery and development. | |
| ImmVue Therapeutics Inc. | , ON | Drug, Therapeutic | immvue.com | david.moon@immvue.com | Less than 10 | Allosteric small molecule precision drug development predicted to replenish patients with T and B lymphocytes with greater fitness to eliminate cancer cells and restore systemic normalcy in various immune mediated diseases. | |
| Insilico Medicine Canada | Montreal, QC | insilicomedicine.com | petrina@insilicomedicine.com | We are a globally leading end-to-end generative AI-driven biotech company in terms of AIDD pipeline progress, with a mission to accelerate drug discovery and development. | |||
| Integrated Nanotherapeutics | BIOTECanada Member | Vancouver, BC | Drug, Therapeutic | integratedntx.com | info@integratedntx.com | 10 to 50 | Integrated Nanotherapeutics is a preclinical company, with strong preclinical POC efficacy data in NOD mice to treat Type 1 Diabetes using mRNA expressing multi-antigens and immune modulators in proprietary multi-cargo LNP. |
| Inteligex Inc | BIOTECanada Member | Toronto, ON | Drug, Therapeutic | inteligexinc.com | paul.bradshaw@inteligex.ca | Less than 10 | Inteligex is a biotech startup focused on delivering novel bioengineered neural stem cell therapies for CNS diseases including spinal cord injury, traumatic brain injury, stroke, multiple sclerosis, and cerebral palsy. |
| Interaxon | Toronto, ON | interaxon.ca | jmf@musehealth.ai | ||||
| Intrepid Labs | Toronto, | intrepidlabs.tech | christine@intrepidlabs.ai | Less than 10 | Intrepid is leveraging active machine learning, advanced robotics and deep pharmaceutical formulation expertise to accelerate the development of therapeutics and platform delivery technologies. | ||
| Intrinsik Corp. | Mississauga, ON | intrinsik.com/services/pharmaceuticals-and-biotechnology | hwilson@intrinsik.com | 50 to 200 | Intrinsik is a science-based consulting firm with clients from all over the world. We specialize in regulatory affairs and nonclinical drug development for small molecules and biologics in North America. | ||
| Invest In Canada | Ottawa, ON | Government | investcanada.ca | Invest in Canada works directly with global investors to unlock business opportunities and facilitate expansion in Canada. | |||
| Invest Quebec | Montreal, QC | investquebec.com/international/en | 200 to 1,000 | Investissement Quebec International is the go-to partner for Quebec-based and foreign businesses seeking to set up or do business in the province. | |||
| Invest Vancouver | Vancouver, BC | Non-Profit, Industry Association, Incubator | investvancouver.ca/Pages | MHenwood@investvancouver.ca | Invest Vancouver is the Metro Vancouver region's economic development leadership service. | ||
| iProgen Biotech Inc. | BIOTECanada Member | Burnaby, BC | Drug, Therapeutic | iprogen.com | klee@iprogen.com | 10 to 50 | iProgen offers proprietary, modular platforms that enhances both the antibody delivery to tumor cells and antibody-receptor internalization. The platform unlocks numerous receptors that were previously overlooked or not considered for ADC development. |
| IRICoR | BIOTECanada Member | Montreal, QC | iricor.ca | claude.larose@umontreal.ca | Less than 10 | IRICoR's main objective is to bridge the translation gap between early-stage academic research and industry. | |
| ITR Laboratories | Baie d'Urfe, QC | Services: Contract Research, Development, Manufacturing | itrlab.com | marketing_group@itrlab.com | 200 to 1,000 | ITR Laboratories Canada, Inc. is a GLP full service preclinical CRO located in Montreal, Canada. We support all aspects of your nonclinical development program, with focus on late-stage toxicology/IND-enabling studies. | |
| Jamp Pharma Corporation | Boucherville, QC | Drug, Therapeutic | jamppharma.ca/en | rgrover@jamppharma.com | 200 to 1,000 | JAMP Pharma Group is one of the fastest growing Bio Pharmaceutical companies in Canada , active in all sectors with BioJAMP biosimilar products, JAMP Pharma generic products, and Orimed Pharma branded/innovative products. | |
| Jenthera Therapeutics Inc. | , QC | Drug, Therapeutic | jenthera.com | laurent.ziri@jenthera.com | Less than 10 | Jenthera is a preclinical gene editing company leveraging its non-viral direct protein delivery CRISPR platform. Solid data from our lead in-vivo CAR-T program strongly support the potential of our platform towards transformative therapies. | |
| JN Nova Pharma | BIOTECanada Member | Ottawa, ON | Drug, Therapeutic | jnova.com | nathan@innova.ca | Less than 10 | Developing Inhalation based therapeutics for IPF, ARDS and IV based therapy for AKI and CKD. Initiating pandemic preparedness program for COVID and H5N1. Interested in meeting potential collaborators to co-apply global funding's. |
| JSS Medical Research | Montreal, QC | Services: Contract Research, Development, Manufacturing | jssresearch.com | pheessels@jssresearch.com | 200 to 1,000 | Global, full-service CRO with offices in USA, Canada, Poland, India & Colombia, over 30 years in market, unique capabilities in the design & execution of Phases I, II, III and post-approval studies. Over 200 projects executed per year, 75% repeat business | |
| Kapoose Creek Bio | BIOTECanada Member | Vancouver, BC | Drug, Therapeutic | kapoosecreekbio.com | eric@kapoosecreek.com | Less than 10 | Kapoose Creek Bio is a platform technology company using the power AI to revolutionize the discovery of medicines from nature and has two exciting leads in optimization for indications in neurology. |
| Kingston Economic Development | Kingston, ON | Non-Profit, Industry Association, Incubator | investkingston.ca | mcilquham@investkingston.ca | 10 to 50 | Invest Kingston is a non-profit committed to making Kingston a leader in life sciences, merging research, healthcare and technology and supporting companies looking to enter the Canadian market | |
| Kisoji Biotechnology | Montreal, QC | Drug, Therapeutic | kbimail.com | gordon.ngan@kbimail.com | 10 to 50 | KisoJi is a transformational antibody company that designs and engineers antibodies. Using multi-species transgenic mice to generate high affinity single domain antibodies, KisoJi uses machine learning to select and engineer multi-specific therapeutics. | |
| Kisolite Corp. | BIOTECanada Member | Squamish, BC | kisolite.com | info@kisolite.com | 10 to 50 | Kisolite Corp is a privately held Canadian biotechnology company commercializing a natural therapeutic bioactive mineral product (Kisolite API) for use in pharmaceutical and consumer health world markets. | |
| Knight Therapeutics Inc. | Montreal, QC | Drug, Therapeutic | gud-knight.com/en | info@gud-knight.com | 200 to 1,000 | Knight Therapeutics Inc. (TSX:GUD) is a publicly-traded, specialty pharmaceutical company focused on in-licensing or acquiring late-stage innovative prescription pharmaceuticals in Canada and Latin AmericaPlease no service provider requests. | |
| KreaMedica | BIOTECanada Member | Montreal, QC | kreamedica.com | KRErlemann@kreamedica.com | Less than 10 | KreaMedica is a strategic investor with a collaborative drug development arm. The internal development team focuses on business assessment and program management. An existing external consultant network works with a vetted network of audited CROs. | |
| KVR Pharmaceuticals Inc | Markham, ON | Drug, Therapeutic | www.kvrpharma.com | KVR Pharmaceuticals Inc. develops innovative products for treatment within the bleeding disorder market and related diseases. Molecules involved in the coagualation pathway are important in other biological mechanisms including cancer. Based in Markham, Ontario the management team have the successsful expertise and skill to identify opportunities not recognized by others | |||
| Kye Pharmaceuticals | BIOTECanada Member | , | kyepharma.com | info@kyepharma.com | 10 to 50 | Kye (pronounced “kai”) is a growth-stage Canadian specialty pharmaceutical company committed to bringing value to Canadians by identifying, in-licensing, and commercializing novel prescription medicines that may not otherwise be made available in Canada | |
| Laurent Pharmaceuticals | Montreal, QC | Drug, Therapeutic | laurentpharma.com | corporate@laurentpharma.com | Less than 10 | Late stage (Phase 2/3) clinical biotech focusing on membrane lipids modulation as a new treatment paradigm for chronic inflammation, host defense and fibrosis. Actively working on Cystic Fibrosis, IPF and Long COVID. | |
| Lavery | Montreal, QC | lavery.ca | slu@lavery.ca | Lavery is an independent full-service law firm with offices in Montreal, Quebec City, Sherbrooke, and Trois-Rivières. | |||
| Life Sciences Ontario | Toronto, Ontario | Non-Profit, Industry Association, Incubator | lifesciencesontario.ca | andy@lifesciencesontario.ca | Life Sciences Ontario is a fully-member funded not-for-profit association that represents the entire life sciences ecosystem in the province from industry, to service providers, academic institutions, regional governments and individual members. We support the life sciences community through advocacy, education, mentorship and networking. We also act as a platform for our members with message amplification via our various marketing channels for our member news, announcements and events; as well as acting as agents of connectivity through our various signature and monthly educational networking events. We work collaboratively with government, industry, academia and all stakeholders to foster a commercially successful life sciences sector in the province and beyond. | ||
| LifeSciences British Columbia | BIOTECanada Member | Vancouver, BC | Non-Profit, Industry Association, Incubator | lifesciencesbc.ca | info@lifesciencesbc.ca | Less than 10 | Life Sciences British Columbia is a not-for-profit, non-government, industry association that supports and represents the life sciences community of British Columbia in Canada. |
| Linearis | Quebec, QC | Services: Legal, Consulting, Business | linearis.com | info@linearis.com | 10 to 50 | Integrated VC fund + AI.Omic Lab investing in life science. The AI.Omic Lab provides precision metabolomic tests and disease signatures for chronic diseases for R&D, diagnostic, Tx. Founding members include Yoshua Bengio (Mila) & David Wishart (TMIC) | |
| Lumerate | Toronto, ON | Digital Health | lumerate.com | 50 to 200 | Lumerate is a Toronto-based tech company whose mission is to power informed industry conversations. Across our three main products, Zymewire, Zapyrus and Zebricks, over 500 companies in the life sciences ecosystem rely on the applications we build. | ||
| Lumira Ventures | Toronto/Vancouver/Montreal, ON/BC/QC | Investor | lumiraventures.com | Founded in 2007, Lumira Ventures is a multi-stage life sciences investment firm with offices in Toronto, Montréal, Vancouver, and Boston. We partner with mission-driven entrepreneurs building companies that harness rapidly evolving advancements in medicine to develop transformative products for patients while delivering strong financial returns for our investors and meaningful economic value and impact for society. | |||
| Lupin Pharma Canada | Montreal, QC | Drug, Therapeutic | lupinpharma.ca | 10 to 50 | Lupin Pharma Canada is a branch of Lupin focused on growing a Specialty Brand business in Canada. Currently specialized in GI and Women's health but looking at Respirology, Ophthalmics and Neuro . | ||
| MaRS Discovery District | Toronto, Ontario | Non-Profit, Industry Association, Incubator | mars.com | msultana@marsdd.com | Canadian innovation hub overseeing a portfolio of 1200+ companies in life sciences, medical devices, climate, and enterprise software. | ||
| McGill University | Montreal, QC | mcgill.ca/research | janet.prince@mcgill.ca | More than 10,000 | McGill's office of Innovation and Partnership seeks partners and collaborators to further develop novel technologies. Currently, McGill has more than 300 inventions with commercial value available for licensing and development by the private sector. | ||
| ME Therapeutics Holdings Inc. | BIOTECanada Member | Vancouver, BC | Drug, Therapeutic | metherapeutics.com | salim@metherapeutics.com | Less than 10 | Preclinical stage Vancouver based biotechnology company involved in the discovery and development of novel immuno-oncology therapeutics targeting immune suppression in cancer. Focussed on drugs targeting myeloid cells. |
| Medicaments Novateurs Canada | Montreal, QC | imc-mnc.ca | cjulien@imc-mnc.ca | Innovative Medicines Canada represents Canada's innovative pharmaceutical industry. We help our members discover, develop and deliver innovative medicines and vaccines. | |||
| Medicenna Therapeutics, Inc | BIOTECanada Member | Toronto, ON | Drug, Therapeutic | medicenna.com | fmerchant@medicenna.com | 10 to 50 | Medicenna is a clinical stage immunotherapy company developing highly differentiated treatments for recurrent glioblastoma, solid tumours, autoimmune diseases and enhanced adoptive cell therapy |
| Mediphage | Toronto, ON | website: mediphage.ca | alvaro.amorrortu@mediphage.ca | ||||
| Mediphage Bioceuticals | BIOTECanada Member | Toronto, ON | Drug, Therapeutic | mediphage.ca | info@mediphage.bio | 10 to 50 | Mediphage is utilizing its proprietary and scalable E. coli-based manufacturing process to manufacture ministring DNA (msDNA), which is a linear, high fidelity, and covalently closed double-stranded DNA vector. |
| Merck Canada Inc | Montreal, Quebec | Drug, Therapeutic | merck.ca/en | For over 130 years, Merck Canada has been providing leading innovations and therapies for many of our world's most challenging diseases in pursuit of our mission to save and improve lives. | |||
| Mesentech | Vancouver, British Columbia | Drug, TherapeuticDrug, Therapeutic | mesentech.com | jpolak@mesentech.com | Mesentech is a clinical stage company developing pharmaceuticals that regenerate muscle and bone. Our lead product, Irodanoprost, is in development for genotype agnostic DMD and other muscular dystrophies. It is a prodrug-conjugate that selectively distributes to the musculoskeletal system. Irodanoprost is well tolerated in an ongoing Phase 1 MAD study when administered weekly for 5 weeks. Preclinical data demonstrate profound benefit to muscle measured by improved functional parameters (increased tensile force) and histological parameters (reduction in fibrosis, fat infiltrates; increased muscle fiber diameter).Mesentech is currently raising $50 million to complete two Phase 2 studies in DMD and FSHD. | ||
| Mesintel Therapeutics | Vancouver, BC | Drug, Therapeutic | mesintel.com | jonathon.jafari@mesintel.com | Less than 10 | Decoding Fibroblast Biology in Order to Develop Superior Therapeutics | |
| Milestone Pharmaceuticals Inc. | Montreal, QC | Drug, Therapeutic | milestonepharma.com | info@milestonepharma.com | 10 to 50 | Milestone is a clinical-stage pharmaceutical company developing a novel therapy for paroxysmal supra-ventricular tachycardia (PSVT) and atrial fibrillation with rapid ventricular rate (AFib RVR). | |
| Molecular Forecaster | BIOTECanada Member | Montreal, QC | molecularforecaster.com | info@molecularforecaster.com | 10 to 50 | MFI tackles the toughest challenges in small molecule drug discovery with world-class computational tools with deep domain expertise. From hit discovery to lead optimization, we bring technology and multidisciplinary knowledge for better research outcomes | |
| Montreal International | Montreal, QC | Non-Profit, Industry Association, Incubator | montrealinternational.com | stephanie.doyle@mtlintl.com | 50 to 200 | Montreal International is a non-profit organization. Its mandate is to attract foreign investment (companies and startups), international organizations, and skilled workers to the Greater Montreal. | |
| Morphocell Technologies | Montreal, | Drug, Therapeutic | morphocell.com | m.paganelli@morphocell.com | Morphocell Technologies is a preclinical regenerative medicine company focused on the commercialization of innovative stem cell therapies aimed at treating severe liver disease. | ||
| MTL In Vivo | Montreal, QC | Non-Profit, Industry Association, Incubator | montreal-invivo.com | info@montreal-invivo.com | Less than 10 | Montreal InVivo is an economic development organization dedicated to the creation of a business environment that fosters innovation and growth of companies and organizations in the life sciences and health technologies (LSHT) sector. | |
| NanoVation Therapeutics | Vancouver, BC | nanovationtx.com | j.kulkarni@nanovationtx.com | 10 to 50 | NanoVation Therapeutics (NTx) is a gene therapy company developing customizable next-gen lipid nanoparticle technologies. Our formulations display increased accumulation in extrahepatic tissues and can be tuned to specific applications. | ||
| Nanovista Inc. | Toronto, Ontario | Diagnostics, Device | nanovista.com | info@nanovista.com | Nanovista develops novel multi-modality imaging agents for real-time tumor visualization and decision support for surgical oncologists. | ||
| National Bank of Canada | BIOTECanada Member | Montreal, QC | Services: Legal, Consulting, Business | nbc.ca | julien.thomas@bnc.ca | More than 10,000 | Public and sponsored finance |
| National Research Council Canada | Ottawa, ON | nrc-cnrc.gc.ca/eng/rd/hht | alexandre.serrano@nrc-cnrc.gc.ca | 1,000 to 10,000 | Canada's premier research organization | ||
| Neomabs Biotechnologies | Montreal, QC | neomabsbio.com | catherine.gagnon@neomabsbio.com | Neomabs Biotechnologies, a company dedicated to developing new immunotherapies for cancer treatment launches in Montreal. | |||
| Neopharm Labs | Blainville, QC | neopharmlabs.com | ycote@neopharmlabs.com | Neopharm offers expert analytical services for the life sciences industry. | |||
| NeoVentures Biotechnology | London, | neoaptamers.com | gpenner@neoventures.ca | 10 to 50 | NeoVentures Biotechnology Europe has developed an innovative platform for high-plex proteomics for biomarker discovery.NeoVentures Biotechnology Canada is the world leader in aptamer development and applications. | ||
| NervGen Pharma Corp. | Vancouver, British Columbia | Drug, TherapeuticDrug, Therapeutic | nervgen.com | NervGen Pharma Corp. is a clinical stage biotech company dedicated to developing innovative treatments that enable the nervous system to repair itself following damage, whether due to injury or disease. | |||
| Neurenati | BIOTECanada Member | Montreal, QC | neurenati.com | maxime@neurenati.com | Neurenati Therapeutics is a pioneering biotechnology company developing an innovative treatment for Hirschsprung disease. | ||
| NeuroSphere (McGill University) | Montreal, Quebec | Non-Profit, Industry Association, Incubator | mcgill.ca/neurosphere | adrienne.crampton@mcgill.ca | NeuroSphere is McGill University’s neuroscience innovation accelerator. NeuroSphere funds and supports neuroscience-related projects, start-ups & core facilities. At BIO 2024 we look to engage with potential collaborators, investors, clients &/or partners | ||
| NL Health Services | St. John's, NL | Non-Profit, Industry Association, Incubator | nlhealthservices.ca | innovation@easternhealth.ca | More than 10,000 | At Newfoundland and Labrador Health Services, we're focused on becoming a key player in clinical trials in Atlantic Canada, ensuring early access to innovative treatments and driving healthcare innovation for better patient outcomes. | |
| Noa Therapeutics | BIOTECanada Member | Toronto, ON | Drug, Therapeutic | noatherapeutics.com | carlaspina@noathera.com | Less than 10 | Noa Therapeutics is a preclinical biotech company pioneering the development of novel small molecules, targeting resolution of barrier dysfunction, to effectively modify pathogenic drivers of inflammatory diseases. |
| Northern RNA Inc. | Calgary, AB | northernrna.com | tmorgan@northernrna.com | 50 to 200 | Northern RNA Inc. is a Canadian CDMO specializing in the production of nucleic acid products. | ||
| Nospharma / District 3 | Montreal, QC | Drug, Therapeutic | nospharma.ca | anmol@nospharma.ca | Less than 10 | District 3 Innovation is an Montreal incubator supporting 9 startups at BIO. They are us supported onsite by Anmol Nagpal, CEO of Nospharma and our EIR. D3 Teams: https://rb.gy/kniq5h*Nospharma is scheduling 1on1s on this profile (see Description)* | |
| Notch Therapeutics | BIOTECanada Member | Vancouver, BC | Drug, Therapeutic | notchtx.com | info@notchtx.com | 50 to 200 | Notch Tx is developing renewable, stem cell-derived immunotherapies, with an initial focus on cancer. |
| Novartis | Montreal, QC | novartis.com | caroline.barber@novartis.com | Novartis is an innovative medicines company. | |||
| Novatek International | Montreal, | Digital Health | ntint.com | sales@ntint.com | 50 to 200 | Since 1996, Novatek International has been providing innovative process-driven LIMS software solutions that target the pharmaceutical, biotech and other health-care industries. | |
| Novateur Ventures Inc. | Vancouver, BC | Drug, Therapeutic | novateur.org | julia@novateur.org | Novateur Ventures is supporting Virogin Biotech for partnering of their lead asset, VG161. Virogin is a clinical-stage Canadian immuno-oncology company developing a pipeline of cancer vaccines, oncolytic viruses, and mRNA therapeutics. | ||
| Novavax Inc. | Oakville, Ontario | Drug, Therapeutic | novavax.com | bseet@novavax.com | Novavax, Inc. is a US-based biotechnology company committed to helping address serious infectious diseases globally through the discovery, development, and delivery of innovative vaccines to patients around the world. | ||
| Novocol Pharma | Cambridge, ON | novocolpharma.com | elee@novocolpharma.com | 200 to 1,000 | Novocol Pharma is a global leading CDMO in sterile injectable cartridge fill finish and combination products device assembly. | ||
| Nucro-Technics, Inc | Toronto, ON | nucro-technics.com | cfanaras@nucro-technics.com | 50 to 200 | Nucro-Technics is a GLP and GMP full service CRO located in Toronto, Canada. With over 50 years of experience, we support all aspects of nonclinical development from your IND through to GMP product release. | ||
| Oligomics | , AB | Drug, Therapeutic | oligomicstx.com | jeff@oligomicstx.com | OligomicsTx Inc. (“Oligomics”)?is a preclinical stage biotechnology company combining ground-breaking novel RNA-targeted therapies with innovative delivery technologies for?rare genetic diseases, including FSHD, DMD, SMA, and FOP. | ||
| OMERS Life Sciences | Toronto, ON | Investor | omers.com | bwu@omers.com | Royalty and Structured Financing | ||
| OmniaBio Inc. | Hamilton, ON | Services: Contract Research, Development, Manufacturing | omniabio.com | cdmo@omniabio.com | OmniaBio (a subsidiary of CCRM) is a cell and gene therapy CDMO offering process development and GMP manufacturing services across iPSCs and other stem cells, immunotherapies (including T, NK, CAR-T, and CAR-NK), and viral vectors (including LVV). | ||
| Omnium Global | , | Services: Legal, Consulting, Business | omnium-global.com | info@omnium-global.com | Omnium Global’s vision is to accelerate timelines to market for an impact on global health by helping companies beat the odds of success in biotech. From strategy inception to seamless business operations, partner with biotech and life science companies, CDMOs, and investors for the full commercialization process. When it comes to complex biologics and advanced therapies, Omnium Global believes no challenge is too big in process intensification, CMC compliance, outsourcing, procurement, or facility design. | ||
| Oncoustics | Toronto, ON | Oncoustics.com | brogozinski@oncoustics.com | 10 to 50 | Oncoustics applies AI to raw ultrasound signals for low cost diagnostics and treatment monitoring of structural and morphological diseases with high unmet need. | ||
| Ontario Bioscience Innovation Organization (OBIO) | BIOTECanada Member | Toronto, ON | obio.ca | info@obio.ca | OBIO® is a not-for-profit, life sciences and health tech accelerator engaged in the development of venture-backed Canadian companies as they raise capital from international VC and strategic partners. | ||
| Ontario Canada Trade & Investment Office | Toronto, ON | Non-Profit, Industry Association, Incubator | investontario.ca | marisa.goepel@international.gc.ca | Representing Ontario, Canada. We help you find new partners for collaboration, advance your R&D, develop and expand clinical trials, and establish operations in Ontario, Canada. | ||
| Ontario Government Representatives | Toronto, ON | ontario.ca | patricia.cosgrove@ontario.ca | ||||
| Ontario Institute for Cancer Research (OICR) | Toronto, ON | oicr.on.ca | info@oicr.on.ca | 200 to 1,000 | OICR is a collaborative research institute that conducts and enables high-impact translational cancer research. We help to accelerate the development of discoveries for patients around the world while maximizing the economic benefit for Ontarians. | ||
| Ontario Ministry of Economic Development | Toronto, ON | Non-Profit, Industry Association, Incubator | sourcefromOntario.ca | patricia.cosgrove@ontario.ca | Support international buyers to procure innovative products, service and technology from Ontario; Facilitate international companies to invest in Ontario. | ||
| Optigo Biotherapeutics Inc. | Vancouver, BC | Drug, Therapeutic | optigobio.com | info@optigobio.com | Optigo Biotherapeutics is an innovative pre-clinical stage biotherapeutics company working to develop cutting-edge treatments to address vision loss from chronic ophthalmic diseases, many of which are currently treated by monthly or bimonthly injections of drugs into the eye(s) by a retina specialist. We believe that by reducing the frequency at which each dose of drug is delivered, we will reduce the inconvenience, discomfort, risk and expense of existing treatments. In doing so, we hope to reduce the number of patients dropping out of their treatment cycles or having to skip doses due to inconvenient timing.? Optigo Bio's pipeline therapy for retinal neovascular diseases and platform technology to enhance durability of approved and future drugs to treat Geographic Atrophy aim to prevent vision loss from these blinding retinal diseases with far fewer injections into the eye. | ||
| Orion Biotechnology | BIOTECanada Member | Ottawa, ON | Drug, Therapeutic | orionbiotechnology.com | 10 to 50 | Orion Biotechnology is a clinical stage biotechnology company developing a new class of highly potent drugs which unlock a set of high-value GPCR targets that have proved difficult to target using traditional drug classes. | |
| Oxford Cancer Analytics | Toronto, ON | oxcan.org | p.liu@oxcan.org | ||||
| Oxymo Technologies | BELOEIL, QC | Drug, Therapeutic | oxymotech.com | ochretien@oxymotech.com | Less than 10 | Oxymo Technologies, a French-Canadian biotech, is developing Oximo, a topical drug product for the treatment of oral and genital herpes | |
| Pacylex Pharmaceuticals Inc. | Edmonton, Canada | Drug, Therapeutic | pacylex.com | michael.weickert@pacylex.com | Less than 10 | Pacylex is developing zelenirstat, a first in class, oral cancer treatment in Phase 2a for NHL and colorectal cancer. Zelenirstat disrupts EGFR, VEGFR, cancer cell signaling, cancer OXPHOS, and more, by targeting the underlying biology, myristoylation. | |
| Paladin Labs, Inc | Montreal, QC | Drug, Therapeutic | paladin-pharma.com | 50 to 200 | Paladin Pharma Inc., headquartered in Montreal, Canada, is a specialty pharmaceutical company focused on acquiring or in-licensing innovative pharmaceutical products for the Canadian market. | ||
| panCELLa | Toronto, ON | Drug, Therapeutic | pancella.com | jake@pancella.com | |||
| panCELLa | Toronto, ON | Drug, Therapeutic | pluristyx.com | info@pluristyx.com | 10 to 50 | Pluristyx, powered by panCELLa, offers end-to-end support to develop Tomorrow's Cell Therapies, Today, by providing best-in-class unmodified and gene edited GMP iPSCs along with process and analytical development services to accelerate the clinical path. | |
| Pangaea Group | Oakville, On | Services: Contract Research, Development, Manufacturing | pangaea-consultants.com | jmartens@pangaea-consultants.com or MLafoley@pangaea-consultants.com | Pangaea Group is a boutique consulting company that has focused on the Canadian Healthcare Industry for over 25 years. Our expertise has helped over 30 International Pharmaceutical companies establish their commercial footprint in Canada. | ||
| Paradox Immunotherapeutics | Toronto, ON | Drug, Therapeutic | paradoximmuno.com | info@paradoximmuno.com | Less than 10 | Biopharmaceutical company dedicated to the creation of antibody therapies for the treatment of rare chronic protein misfolding diseases, including those characterized by amyloidosis. | |
| Partner International | Dartmouth, NS | Services: Legal, Consulting, Business | partner-intl.com | info@partner-intl.com | 10 to 50 | Partner International is a leading outsourced business development company, focused on partnering, licensing, and M&A transactions globally. | |
| Pattern Pharma | BIOTECanada Member | Toronto, ON | Drug, Therapeutic | patternpharma.com | mdegroot@patternpharma.com | ||
| Pattern Pharma Inc. | Toronto, ON | Drug, Therapeutic | biointernationalconvention20.hubb.me/schedule-builder/sessions | info@patternpharma.com | Less than 10 | Pattern is a therapeutics company focused on harnessing innate immunity to combat cancer and infectious diseases. Its initial focus is on a large, white-space opportunity in oncology to address the high 5 year post-surgery relapse rate in cancer patients. | |
| Pegasus Biotech | Charlottetown, Canada, Prince Edward Island | Services: Contract Research, Development, Manufacturing | pegasusbio.com | yimymena@pegasusbio.com | Pegasus Biotech is a contract research organization (CRO) based in PEI, Canada, serving the global vaccine and biopharmaceutical industry. The Pegasus team is comprised of experts in process and analytical development supporting clients in the human and animal health industries. Our mission at Pegasus Biotech is to work with our clients to bring cutting edge innovation to the global human and animal health markets. Our area of expertise is ensuring that development activities for client projects, in the proof-of-concept stage or moving into production, result in commercially viable products that are compliant with global regulations. | ||
| PEI Bioalliance | BIOTECanada Member | Charlottetown, PE | Non-Profit, Industry Association, Incubator | peibioalliance.com | rory@peibioalliance.com | 10 to 50 | The Prince Edward Island Bioscience Cluster is a Canadian centre of expertise in health product development and biomanufacturing, from APIs to biologics and natural product chemistry, with applications in human health, veterinary products and fish health. |
| Pendopharm | Montreal, QC | pendopharm.com | hghanei@pendopharm.com | Pendopharm is the branded specialty division of Pharmascience Inc. dedicated to developing, in-licensing and commercializing innovative products to improve the lives of Canadian patients and their families. | |||
| Perceiv AI | Montreal, QC | perceiv.ai | info@perceiv.ai | Less than 10 | Perceiv is a precision medicine company pioneering disease forecasting to transform clinical trials. We are developing a multimodal prognostic platform to forecast disease progression in neurological disorders starting with Alzheimer's. | ||
| Pharmascience | Montreal, QC | pharmascience.com | 1,000 to 10,000 | Pharmascience Inc. is a full-service privately owned pharmaceutical company with strong roots in Canada and a growing global reach with product distribution in over 50 countries; and annual sales of about C$ 1 billion. | |||
| pharmBD | Montreal, QC | pharmbd.com | info@pharmbd.com | PharmBD represents different lifescience companies and partners carrying portfolio of clinical stage or market-ready products for out-licensing in various markets. We are actively seeking partners, please check out our asset portfolio for more info. | |||
| Pharmbd Inc. | montreal, Quebec | Services: Legal, Consulting, Business | Pharmbd.com | Hmoore@pharmbd.com | PharmBD is a boutique-style business and corporate development company specializing in supporting clients to craft strategic partnerships for their assets in development. The company also assists customers in enriching their portfolios with new products. PharmBD provides strategic advising services in the fields of pharmaceutical, biotech and medtech globally. | ||
| PHARMDSIDE INC. | Laval, | pharmdside.com | info@pharmdside.com | Less than 10 | seeking commercial and late stage in-licensing or acquisition of products for the Canadian and Eastern Central European markets. Clients include Bausch Health Canada | ||
| Phyton Biotech | Delta, BC | Services: Contract Research, Development, Manufacturing | phytonbiotech.com | sball@phytonbiotech.com | 50 to 200 | Contract fermentation company focussed on Plant Cell Fermentation. Development & manufacturing of high-value plant-based molecules, other specialized fermentation and purification services, large-scale GMP facilities (up to 75,000L) | |
| Plantform | BIOTECanada Member | Toronto, ON | Drug, Therapeutic | plantformcorp.com | don.stewart@plantformcorp.com | 10 to 50 | PlantForm Corporation is a Canadian biotech company with an innovative, low-cost plant based manufacturing system for a wide range of pharmaceuticals and high value proteins for all purposes. |
| PolyAnalytik Inc. | London, ON | polyanalytik.com | info@polyanalytik.com | 10 to 50 | Contract research organization that specialized in purification, R&D, CMC, and Pre-clinical testing of medical technologies including nanoparticle drug delivery systems, biodegradable coatings, antibody conjugates, peptides, and enzymes. | ||
| ProteinQure Inc | BIOTECanada Member | Toronto, ON | proteinqure.com | lucas@proteinqure.com | 10 to 50 | ProteinQure has the best computational platform for peptide design. We have collaborations with AstraZeneca, Daiichi Sankyo(including in-vivo validation). We are seeking additional partnerships. Including our proprietary libraries and delivery peptide. | |
| PTL Solutions Inc. | Montreal, Quebec | Diagnostics, Device | ptl-solutions.com | thomas.moore@ptl-solutions.com | A medical device consulting firm that provides support in regulatory affairs, quality management, product development and go-to-market strategy and implementation. We have experts with significant experience and the flexibility of providing fractional support. | ||
| PurMinds NeuroPharma | Bolton, ON | Drug, Therapeutic | purminds.com | janet@purminds.com | 10 to 50 | PurMinds is a neuro-medicine company pursuing breakthrough solutions to neurological disorders. We have a small molecule pipeline focusing on serotonin-inspired neuroplastogens and disease altering HDAC6 inhibitors. | |
| Q&C Services Inc. | BIOTECanada Member | Mississauga, ON | Services: Legal, Consulting, Business | qualityandcompliance.com | info@qualityandcompliance.com | 50 to 200 | Q&C is the largest full-service consultant and importer for Health Canada regulated products. With 30 years of experience, we provide expert regulatory and compliance consulting for importing drugs, APIs, NHPs and medical devices into Canada |
| Q-CROC | Quebec City, QC | qcroc.ca | ldamours@qcroc.ca | Q-CROC develops solutions to optimize participant recruitment and improve clinical research knowledge. | |||
| QReserve | Hamilton, ON | Digital Health | get.qreserve.com | dominique.krawchenko@qreserve.com | |||
| Qu Biologics Inc. | BIOTECanada Member | Burnaby, BC | Drug, Therapeutic | qubiologics.com | hal@qubiologics.com | 10 to 50 | Qu's Site Specific Immunomodulators (SSIs) are uniquely designed to restore all the dysregulated cells, pathways, and functions of innate immunity in a targeted diseased organ to fundamentally transform the treatment of inflammatory diseases and cancer. |
| Quebec International | QUEBEC, Canada | Non-Profit, Industry Association, Incubator | quebecinternational.ca/en/choose-quebec/quebec-industries | jmgarro@quebecinternational.ca | 50 to 200 | Regional Economic Development Agency | |
| QurCan | BIOTECanada Member | Toronto, ON | qurcan.com | ma.amini@qurcan.com | |||
| R&R International Translation Specialists Inc. | Pointe-Claire, Québec | Services: Legal, Consulting, Business | rr-translations.com | marlie@rr-translations.com | R&R International Translation Specialists Inc. is a Quebec-based company that provides high-quality translation services within the life sciences sector. We specialize in translating a wide range of documents, including regulatory submissions, clinical trial materials, and scientific publications, ensuring accuracy and compliance with industry standards. Our goal is to facilitate clear and precise communication within the life sciences community, supporting advancements in healthcare and research. | ||
| Radiant Biotherapeutics | , QC | Drug, Therapeutic | radiantbiorx.com | afratamico@radiantbiorx.com | Less than 10 | Radiant is developing a platform of multi-valent and multi-specific antibodies which we call Multabodies. Our Multabodies, are multi-valent and multi-specific antibodies on a fully human back bone with exquisite potency and efficacy. | |
| Rakovina Therapeutics | Vancouver, BC | Drug, Therapeutic | rakovinatherapeutics.com | info@rakovinatherapeutics.com | Less than 10 | Rakovina Therapeutics Inc. (TSX-V: RKV) is focused on the discovery and development of new cancer treatments based on novel DNA-damage response targeting agents using proprietary Deep Docking(TM) AI algorithm. | |
| Rapid Novor | Kitchener, ON | rapidnovor.com | mxie@rapidnovor.com | 50 to 200 | Rapid Novor Inc is the world's leading protein sequencing company specializing in antibodies. Through the use of machine learning and mass spectrometry the team has revolutionized the way we use big data on the very smallest pieces of nature. | ||
| Raya Therapeutic | Montreal, | Drug, Therapeutic | rayatherapeutic.com | admin@rayatherapeutic.com | Less than 10 | Raya is focused on developing drugs to treat ALS. The company has secured 5 clinical stage compounds (all NCEs) with different MOAs that all have potential to treat ALS. The company is planning to start a dedicated P3 Platform Trial in Q1 of 2025. | |
| Repare Therapeutics | BIOTECanada Member | Saint-Laurent, QC | Drug, Therapeutic | reparerx.com | 50 to 200 | Repare Therapeutics (Nasdaq: RPTX) is a leading precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics. | |
| ResearchNB | Fredericton, New Brunswick | Non-Profit, Industry Association, Incubator | researchnb.ca | damon@researchnb.ca | ResearchNB is New Brunswick, Canada’s research and innovation hub, supporting health and bioscience sectors to improve the lives of New Brunswickers. | ||
| RJH Biosciences Inc | Edmonton, AB | Drug, Therapeutic | rjhbiosciences.com | rjhbiosciences@gmail.com | Less than 10 | RJH Biosciences is a biotechnology company whose focus is to realize the full potential of nucleic acids for human health. We develop novel transfection reagents and delivery systems that transport different types of nucleic acids to a range of cells. | |
| RNA TECHNOLOGIES | Montreal, QC | rnatechnologies.com | info@rnatechnologies.com | RNA Technologies and Therapeutics Inc. is a Montreal-based company specializing in designing and producing high-quality RNA, including nucleoside-modified messenger RNAs, and developing mRNA-based technologies and targeted therapeutics. | |||
| Royal Alexandria Hospital Foundation | Edmonton, Alberta | Non-Profit, Industry Association, Incubator | Royalalex.org | mwax@royalalex.org | The Foundation funds advanced education, cutting-edge research, next-generation technologies and facility improvements that advance care and enhance the patient experience. Our VisionImproving the health of Albertans by building passionate community support for the Royal Alexandra Hospital.Our MissionThe Royal Alexandra Hospital Foundation inspires community support for the Royal Alexandra Hospital and its medical centres of excellence, including the Lois Hole Hospital for Women, the CK Hui Heart Centre, the Eye Institute of Alberta and the Orthopedic Surgery Centre. | ||
| SaNOtize Research & Development | Vancouver, BC | Drug, Therapeutic | sanotize.com | gilly@sanotize.com | 10 to 50 | SaNOtize is a global, clinical-stage therapeutics company based in Vancouver, Canada. Its patented technologies deliver the natural antimicrobial properties of nitric oxide (NO) to treat a wide range of common viral, bacterial, and fungal infections. | |
| Scatr Medical | Toronto, ON | Drug, Therapeutic | scatr.ca | ari@scatr.ca | Less than 10 | Scatr Medical is developing the first-ever breakthrough combination drug which will reverse overdoses of a variety of respiratory depressants, most notably xylazine, which the white house designated as a public health threat last year. | |
| Scimega Research Inc. | Montreal, QC | Services: Contract Research, Development, Manufacturing | scimega.com | julie@scimega.com | 10 to 50 | Scimega is a niche CRO with a singular focus in oncology clinical trials (Phase 1, 2 & Phase 3). With privileged site relationships across Canada we help small & mid-sized biopharma clients achieve exceptional results. | |
| Searchlight Pharma Inc. | Montreal, QC | Drug, Therapeutic | searchlightpharma.ca | info@searchlightpharma.ca | 50 to 200 | *No service providers please*Searchlight Pharma is a Canadian-based specialty healthcare company dedicated to improving human health and wellness through the acquisition, commercialization, and focused development of unique healthcare products. | |
| Seragene Therapeutics | Vancouver, | Drug, Therapeutic | seragenetx.com | e.siren@seragenetx.com | Less than 10 | SeraGene Therapeutics is a pre-clinical stage biotech company committed to reimagining the treatment of coagulation disorders through innovative RNA and nanomedicine technologies | |
| Sernova Corp. | BIOTECanada Member | London, ON | sernova.com | info@sernova.com | 10 to 50 | Sernova (TSX: SVA; OTCQB: SEOVF; FSE/XETRA: PSH) is a clinical-stage biotech company developing a portfolio of therapeutic cell technologies for treatment of chronic diseases, including insulin-dependent diabetes, hypothyroid disease, and hemophilia A. | |
| Shared Health Manitoba | Winnipeg, Manitoba | Services: Contract Research, Development, Manufacturing | healthproviders.sharedhealthmb.ca/services/research-and-innovation | pbeaudin@sharedhealthmb.ca; | Shared Health Manitoba operates HSC Winnipeg and is a non-profit Provincial Health Services Organization. We are a key player in clinical trials and health system innovations that provide early access to innovative treatments and improved outcomes to our patients. | ||
| Simmunome | Montreal, QC | Services: Contract Research, Development, Manufacturing | simmunome.com | Simmunome is a techbio company leveraging generative AI to enhance predictability of clinical drug development and prevent late-stage failures. | |||
| Sinoveda Canada Inc. | Edmonton, | sinoveda.com | ntzaman@sinoveda.com | Sinoveda Canada Inc. adopts an innovative approach to drug discovery by starting with herbs that have a historical record of efficacy. This means that the company focuses on plant-based medicine with a proven track record in traditional medicinal practices. By combining this knowledge of historically effective herbs with their patented pharmaceutical platform technology (PPT), AI, and machine learning, Sinoveda aims to identify and develop novel combination therapies with high efficacy and safety profiles. This unique approach integrates traditional wisdom with cutting-edge technology to advance the drug discovery process and deliver promising new treatments. | |||
| Sirona Biochem Corp | Vancouver, British Columbia | Drug, Therapeutic | sironabiochem.com | hverrico@sironabiochem.com | Sirona Biochem uses advanced chemistry techniques to create patented, active compounds for commercial applications. Seeking partners for clinical-stage compounds in anti-aging, skin and pigmentation disorders. Also preclinical for anti-cellulite. | ||
| Solve FSHD | Vancouver, BC | Investor | solvefshd.com | klam@solvefshd.com | Founded in 2022 with a US$100M commitment from lululemon founder Chip Wilson, Solve FSHD is a philanthropic venture organization focused on funding new approaches to treat Facioscapulohumeral Muscular Dystrophy (FSHD). We partner with academia and industry to catalyze the pace of innovation to accelerate a cure for FSHD, and fund drug-discovery research and non-clinical development through to IND filings and clinical trials. We focus on bottlenecks and high-risk approaches, balancing investments in traditional approaches and advanced cutting-edge technologies. | ||
| Somru Bioscience | Charlottetown, Prince Edward Island | Services: Contract Research, Development, Manufacturing | somru.ca | moin@somrubioscience.com | Our company, located in PEI, Canada, specializes in providing bioanalytical and characterization services for large molecule therapeutics. We have advanced technology platforms including Flow Cytometry, ELISpot, PCR, MSD, Gyros, and ELISA. In addition, we offer ultra-sensitive immunoassay services with our proprietary Amplatto technology, and advanced functional characterization of biologics with our IntelliB technology. | ||
| Specific Biologics Inc. | BIOTECanada Member | Toronto, ON | Drug, Therapeutic | specificbiologics.com | 10 to 50 | Specific Biologics is a venture-backed early stage company developing a platform gene editing technology. | |
| Spectrum Pharma | Saint-Laurent, QC | spectrumpharma.ca | dgirard@spectrumpharma.ca | Founded in 1987 in Montreal, Spectrum Pharma provides packaging services to many of the world's largest pharmaceutical companies. | |||
| Spectrum Pharma Packaging | St-Laurent, QC | Services: Contract Research, Development, Manufacturing | www,spectrumpharma.ca | eazoulay@spectrumpharma.ca | 10 to 50 | Short descriptive sentence Spectrum offers unique expertise in clinical trial supply chain management, both nationally and internationally. Services offered include primary and secondary packaging, labeling, warehousing and worldwide distribution. | |
| Spektar Therapeutics | , | Drug, Therapeutic | spektartx.com | contact@spektartx.com | 10 to 50 | Spektar Therapeutics invests in the licensing, development and commercialization of specialty medicines in the CNS segment. | |
| Spiderwort Inc | BIOTECanada Member | Ottawa, ON | Diagnostics, Device | spiderwortbio.com | info@spiderwortbio.com | 10 to 50 | Spiderwort develops cellulose-based scaffolds for use in applications in regenerative medicine. |
| St-Amour a division of Groupe Magellan | Montreal, Québec | Services: Legal, Consulting, Business | st-amour.com | sriverin@st-amour.com | At Magellan and St-Amour, we go beyond traditional recruitment, we offer you a complete solution.We are not content only to find the right candidate, you also benefit from our consulting services throughout the recruitment process, until the integration of your new employee. Magellan puts its expertise at your disposal in order to offer a complete support offer, services that are both innovative and demanding. | ||
| Stem Cell Network | Ottawa, ON | Non-Profit, Industry Association, Incubator | stemcellnetwork.ca | catemurray@stemcellnetwork.ca | The Stem Cell Network (SCN) is a Canadian not-for-profit that supports stem cell and regenerative medicine research; training the next generation of highly qualified personnel; and knowledge mobilization and transfer of stem cell and regenerative medicine | ||
| STEMCELL Technologies | Vancouver, British Columbia | Services: Contract Research, Development, Manufacturing | stemcell.com | david.llewellyn@stemcell.com | STEMCELL Technologies supports life sciences research with more than 2,500 specialized reagents, tools, and services. STEMCELL offers high-quality cell culture media, cell separation technologies, instruments, accessory products, educational resources, and contract assay services that are used by scientists performing stem cell, immunology, cancer, regenerative medicine, and cellular therapy research globally. | ||
| SteriMax Inc. | Oakville, ON | Drug, Therapeutic | sterimaxinc.com | businessdevelopment@sterimaxinc.com | 50 to 200 | ||
| Stiris Research Inc. | London, ON | Services: Contract Research, Development, Manufacturing | stirisresearch.com | info@stirisresearch.com | 50 to 200 | Stiris Research is a privately held, woman-owned, entrepreneurial clinical research organization (CRO). Established in 2004, Stiris manages Phase I through Phase III clinical trials for pharmaceutical, biotechnology companies. | |
| Sustained Therapeutics | BIOTECanada Member | , BC | Drug, Therapeutic | sustainedtherapeutics.com | wannett@sustainedtx.com | Sustained Therapeutics is a clinical stage company developing a drug delivery platform technology initially focused on non-opioid pain medication, but extendable to other APIs including significant oncology indications. | |
| TACTIX Government Relations and Public Affaires | Ottawa, Ontario | Services: Legal, Consulting, Business | tactix.ca | alain.madgin@tactix.ca | TACTIX offers unparalleled experience in solving complex public affairs threats and opportunities in Canada. TACTIX is the exclusive Canadian member of The Advocacy Group (TAG) (https://theadvocacygroup.org), the premier municipal, state, federal and international government and public affairs organization in the world. | ||
| Targa Biomedical | BIOTECanada Member | Montreal, QC | Drug, Therapeutic | targabiomedical.com | shant.ds@targabiomedical.com | Targa Biomedical is a clinically focused biotechnology company that develops innovative solutions for large global unmet needs in transplantation and regenerative medicine. | |
| TATUM Bioscience | , | Drug, Therapeutic | tatumbio.com | info@tatumbio.com | Less than 10 | We are pioneering nanofilament immunotherapy, a radically new therapeutic approach unleashing the true potential of immuno-oncology. | |
| Technopole maritime du Quebec | Rimouski, QC | tmq.ca | msoubirou@tmq.ca | Technopole maritime du Quebec is a non-profit organization dedicated to the promotion and development of Quebec's innovative maritime sectors. | |||
| Teralys Capital | Montreal, QC | Investor | teralyscapital.com | Teralys Capital is the largest fund of funds in Canada with a dedicated focus on investing in life sciences funds and selected later stage direct opportunities. | |||
| The Hospital for Sick Children | Toronto, ON | ipc.sickkids.ca | ipc.requests@sickkids.ca | 1,000 to 10,000 | SickKids is seeking partnerships with biotech, pharmaceutical companies and venture capital investors to advance our innovations through licensing, newco creation or other parnerships. | ||
| Theratechnologies, Inc | Montreal, QC | Drug, Therapeutic | theratech.com | 50 to 200 | Theratechnologies Inc. (TSX: TH) (NASDAQ: THTX), is a specialty biopharmaceutical company focused on the commercialization of innovative therapies targeting specialty diseases with high unmet needs. | ||
| TheraVac Biologics | Mississauga, ON | theravacbio.com | a.riazi@theravacbio.com | ||||
| Toronto Innovation Acceleration Partners (TIAP) | BIOTECanada Member | Toronto, ON | Investor | tiap.ca | 10 to 50 | Toronto Innovation Acceleration Partners (TIAP) specializes in venture creation and investment in early-stage innovative life sciences technologies emerging from Canada's largest innovation cluster including University of Toronto & 9 affiliated hospitals | |
| Transpharmation Canada Ltd. | Fergus, ON | transpharmation.com | joseph.araujo@transpharmation.com | ||||
| Treventis Corporation | Toronto, ON | Drug, Therapeutic | treventis.com | cbarden@treventis.com | 10 to 50 | Small molecule preclinical company with drugs targeting misfolded proteins in cancer, neurodegeneration and other protein misfolding disorders. Treventis' unique drug design platform against misfolded proteins enables an unexplored disease-modifying drug | |
| Triple Hair | , | Drug, Therapeutic | triplehair.ca | info@triplehair.ca | Less than 10 | Triple Hair is a biotechnology company developing innovative treatments for alopecia. Triple Hair is attending Bio with the aim of developing partnerships with strategic investors and meeting pharmaceutical companies interested in licensing opportunities. | |
| Trudell Medical International | , | Diagnostics, Device | trudellmed.com | jsuggett@trudellmed.com | TMI is a Canadian headquartered global company that designs, develops, manufactures and sells respiratory medical devices. Our devices are registered in all major markets and supported by significant lab and clinical research. | ||
| TVM Life Science Management GmbH | Westmount, QC | Investor | tvm-lifescience.com | info@tvm-capital.com | TVM Capital Life Science is a dedicated provider of venture capital to the international pharmaceutical, medical technology and healthcare diagnostics industries. | ||
| University Health Network | Toronto, ON | uhncommercialization.ca | commercialization@uhn.ca | More than 10,000 | University Health Network (UHN) is a globally recognized academic research hospital known for its pioneering scientific discoveries and advanced clinical capabilities. It is the leading medical research commercialization centre in Canada. | ||
| University Hospital Foundation | Edmonton, AB | givetouhf.ca | michelle.ponich@givetouhf.ca | The University Hospital Foundation is a group of passionate catalysts with a unified vision to transform and redefine health in the Edmonton area, throughout Alberta, and around the world.; ; We inspire, connect, and empower world-class hospitals, doctors, researchers, and clinicians to realize the critical treatments, cures, and possibilities that exist beyond today's bedside. We bring health innovation leaders from private industry together with Alberta's health ecosystem to provide hope for living healthier lives. | |||
| University of Alberta | Edmonton, AB | Academic | ualberta.ca/research | dgfast@ualberta.ca | The University of Alberta in Edmonton is one of the top teaching and research universities in Canada, with an international reputation for excellence across the humanities, sciences, creative arts, business, engineering and health sciences. | ||
| University of Alberta, OVPRI | Edmonton, AB | Academic | ualberta.ca | The University of Alberta in Edmonton is one of the top teaching and research universities in Canada, with an international reputation for excellence across the humanities, sciences, creative arts, business, engineering and health sciences. | |||
| University of Calgary | Calgary, AB | research.ucalgary.ca | sid.gunamalai@ucalgary.ca | More than 10,000 | UCalgary researchers are partnering withindustry sponsors to turn knowledge intobreakthrough treatments, diagnostics, devicesand solutions. | ||
| University of Manitoba | Winnipeg, MB | Academic | umanitoba.ca | Partnerships@umanitoba.ca | 1,000 to 10,000 | The Partnerships and Innovation office works to increase the number of partnerships between our researchers and groups outside the University of Manitoba, and move inventions from research labs into practical applications that can be used around the world | |
| University of Toronto | Toronto, ON | research.utoronto.ca | More than 10,000 | ||||
| University of Toronto Mississauga | Mississauga, ON | Academic | spinup.utm.utoronto.ca | spinup@utoronto.ca | 1,000 to 10,000 | SpinUp is the University of Toronto's wet lab-based, early-stage startup incubator. We look forward to meeting prospective partners interested in connecting with SpinUp, and with our startups that align with your organization's priority areas. | |
| Vaccine and Infectious Disease Organization (VIDO) | BIOTECanada Member | Saskatoon, SK | vido.org | jf.rodriguez@usask.ca | 50 to 200 | Originally established in 1975, we have evolved from a small agricultural focused research organization to a world-class research institute dedicated to the development of vaccines for the protection of human and animal health. | |
| Vancouver Island Life Sciences association | Victoria, BC | Non-Profit, Industry Association, Incubator | vils.ca | sam@vils.ca | Vancouver Island Life Sciences association (VILS) is a volunteer nonprofit organization linking together and supporting life sciences companies and innovators across Victoria and the island. | ||
| Variational AI Inc. | Vancouver, BC | Drug, Therapeutic | variational.ai | handol@variational.ai | 10 to 50 | Generative AI platform for drug discovery | |
| Vasomune Therapeutics, Inc. | BIOTECanada Member | Toronto, ON | Drug, Therapeutic | vasomune.com | Bjahns@vasomune.com | Less than 10 | Vasomune Therapeutics is a private clinical stage biopharmaceutical company that has successfully applied basic research to developing therapeutic assets promoting vascular stabilization. |
| VentureRise Global Inc | London, ON | Services: Legal, Consulting, Business | ventureriseglobal.com | A platform built by seasoned professionals, in both Canada and Asia, with a track record of successful technology commercialization and investment deal making. VentureRise Global seeks to be an effective force facilitating more international partnerships in commercializing science and technology advancement. | |||
| VeriLuce Therapeutics Inc. | Toronto, ON | Drug, Therapeutic | verilucetherapeutics.com | elena.frigerio@verilucetherapeutics.com | Less than 10 | Veriluce is a Company in the immuno-oncology modulation space currently developing a platform of novel small molecules targeting concomitantly 2 specific GPCR chemokine receptors in dual antagonstic mode to block cancer cell growth and metastasis. | |
| Virica Biotech | BIOTECanada Member | Ottawa, ON | viricabiotech.com | info@viricabiotech.com | 10 to 50 | Virica is a viral vector enhancer company. We pioneered a production enhancer category called VSE™, small molecules that removes the barriers to manufacturing effective viral medicines at scale. | |
| Virogin Biotech Ltd | , BC | Drug, Therapeutic | virogin.com | hyzhao@virogin.com | Virogin Biotech is a clinical-stage immuno-oncology company, with a primary focus on innovative HSV-1 based oncolytic virotherapy (OV) and RNA-based vaccines to elicit robust and durable anti-tumor immune response against solid tumors. | ||
| VJO Canada, Inc | Pointe-Claire, QC | vjocanada.net | verkin@vjocanada.net | We partner with companies to accelerate and advance drug development programs in parallel to their exit strategy, We work in the CMO, preclinical and clinical space. | |||
| VoxCell BioInnovation | Victoria, BC | voxcellbio.com | kvos@voxcellbio.com | 10 to 50 | VoxCell is creating Vascularized Human-like Cancer Tissue Models for Preclinical Tests. | ||
| Western University | London, ON | Drug, Therapeutic | uwo.ca | kplacide@uwo.ca | At Western University, ranked within the top 1% of higher education institutions worldwide, we are pioneering a new era in biotechnology and pharmaceutical research. With a community of over 100 specialized neuroscience researchers and 14 Canada Research Chairs, we are pushing boundaries in the treatment and understanding of neurodegenerative diseases.Why Partner with Western University:Neuroscience and Neurodegenerative Disease Research: The TRanslational Initiative to DE-risk NeuroTherapeutics (TRIDENT), bolstered by a $24 million grant from the Government of Canada's New Frontiers in Research program, positions Western at the leading edge of neurodegenerative disease research. TRIDENT's humanized pre-clinical trials, equipped to emulate human clinical studies' complexity, including cognitive assessments and neuroimaging, fast-track the development of neurological treatments from Alzheimer's to Parkinson's and ALS.Clinical and Preclinical Trials: Western's infrastructure is uniquely designed to reflect human clinical trial parameters, facilitating profound exploration and translation of therapies from controlled pre-clinical settings to patient care. Supported by an extensive patient base from three primary hospitals, Western excels in expediting the treatment lifecycle, from research to market.Oncology Research and Development: Our oncology research complements our neuroscience expertise, with researchers engaged from fundamental molecular science to translational oncology trials. Our work in developing cancer treatments and personalized medicine is enhanced by our focus on theranostics, integrating therapy with diagnostics for precise, targeted interventions.Molecular Imaging and Theranostics: The CFMM houses Canada's exclusive high-field and ultra-high field MRI systems, including an innovative 15.2 Tesla MRI, solidifying our lead in neuroimaging and theranostics. This unique combination propels personalized medicine, offering targeted treatments based on detailed diagnostics.From Laboratory to Lifesaving Therapies:Our collaborative ecosystem, boasting advanced imaging technology and strong hospital partnerships, sets the stage for impactful translational research. Our commitment is to ensure that our scientific discoveries lead to improved health outcomes, supporting the full spectrum from molecular research to patient treatment.An Invitation to Action:We call on the biotech and pharma industries to explore partnership opportunities with Western University. Join us as we transform visionary ideas into life-enhancing realities. Let's engage in discussions on how our partnership can open new avenues and accelerate healthcare innovation. Connect with us to shape the future of medicine, driving forward from groundbreaking research to the development of next-generation treatments. Together, at Western University, your goals for progress and impact can find a collaborative and dynamic environment. | ||
| WEX Pharmaceuticals Inc. | BIOTECanada Member | Vancouver, BC | Drug, Therapeutic | wexpharma.com | wex@wexpharma.com | 10 to 50 | Phase 3 program on the use of the sodium channel blocker, Halneuron® (tetrodotoxin), as an analgesic. |
| xCellarate Technology Consulting Inc | Vancouver, BC | Services: Legal, Consulting, Business | xcellarate.ca | fenton@xcellarate.ca | CMC, quality, regulatory | ||
| XEDITON PHARMACEUTICALS INC. | Mississauga, ON | Drug, Therapeutic | xediton.com | info@xediton.com | 10 to 50 | Xediton Pharmaceuticals is a privately-held Specialty Pharma company with a focus on meeting the needs of patients, physicians and partners. We are located in the Greater Toronto Area, Ontario, Canada. | |
| Xenon Pharmaceuticals, Inc | BIOTECanada Member | Burnaby, BC | Drug, Therapeutic | xenon-pharma.com | info@xenon-pharma.com | 200 to 1,000 | Xenon Pharmaceuticals (NASDAQ:XENE) is a clinical stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders. |
| XORTX Therapeutics Inc. | Calgary, AB | Drug, Therapeutic | XORTX.com | adavidoff@xortx.com | XORTX Therapeutics, Inc. is a drug based biotechnology company primarily focused on orphan disease indications which have aberrant purine metabolism and frequently high serum uric acid imbalance. Our focus on developing kidney therapies also includes therapeutics programs for large markets such as diabetic nephropathy and acute kidney injury associated with respiratory virus infections such as SARS-CoV-2.; ; We possess patents and patent applications that may include U.S. and international rights regarding the development of uric acid-lowering agents for the treatment of hypertension, insulin resistance, diabetes, metabolic syndrome, and kidney injury. | ||
| YYZ Pharmatech Inc. | Toronto, | yyzpharmatech.com | Less than 10 | YYZ Pharmatech is revealing the entire human plasma proteome. Previously unseen biomarkers and drug targets can now be discovered and ultra-sensitively assayed from human patient blood samples with YYZ's novel technologies. | |||
| Zucara Therapeutics Inc. | BIOTECanada Member | Toronto, ON | Drug, Therapeutic | zucara.ca | mmidmer@zucara.ca | Less than 10 | Meeting a critical need to help prevent hypoglycemia in patients with diabetes |
| Zymeworks | BIOTECanada Member | Vancouver, BC | Drug, Therapeutic | zymeworks.com | info@zymeworks.com | 200 to 1,000 | Zymeworks (Nasdaq: ZYME) is a global biotechnology company committed to the discovery, development, and commercialization of novel, multifunctional biotherapeutics. |